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ABSTRACT
ISOLATION AND FUNCTIONAL MAPPING OF HUMAN T-CELL LEUKEMIA 
VIRUS TYPE 1 TAX ONCOPROTEIN DNA-DAMAGE COMPLEXES
Sarah Saionz Durkin 
Old Dominion University, 2006 
Chair: Dr. O. John Semmes
Human T-cell Leukemia Virus Type 1 (HTLV-1) is a transforming retrovirus 
which causes Adult T-cell Leukemia (ATL) and HTLV-1 Associated 
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Cellular transformation can be 
caused by a single viral frans-activating protein, Tax. Tax may contribute to 
transformation through interaction with components o f the DNA damage response 
pathway, promoting cellular genomic instability. We examined cellular Tax complexes 
in an effort to elucidate potential protein-protein interactions that can model the Tax- 
induced molecular events. We also investigated the role of post-translational 
modification in regulating Tax function.
We employed a direct physical analysis o f Tax complexes isolated from 
mammalian cells using affinity purification followed by liquid chromatography/tandem 
mass spectrometry (LC-MS/MS) analysis, in order to identify both Tax-interacting 
proteins as well as post-translational modifications o f the Tax protein itself. We 
identified the DNA-dependent Protein Kinase catalytic subunit (DNA-PKcs) as a novel 
Tax-interacting protein. Using bio informatics analysis, we created a database o f Tax- 
interacting proteins and, using this tool, identified DNA-PKcs as a predicted member of 
the Tax complex.
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Physical mapping of purified Tax protein revealed novel phosphorylation sites at 
T48, T184, T215 and S336. Mutational analysis demonstrated phosphorylation at T215 
is associated with loss o f Tax trans-activation of CREB and NF-icB-responsive 
promoters, while T48 preferentially affects NF-KB-responsive promoters, and T184 and 
S336 have no effect on these Tax functions.
We confirm the presence of DNA-PKcs and the regulatory protein Ku70 in the 
Tax complex by co-immunoprecipitation. Tax increases phosphorylation of DNA-PKcs 
and co-localizes with phosphor-DNA-PKcs within nuclear Tax Speckled Structures 
(TSS). Cytoplasmically-localized Tax deletion mutants cause a redistribution of 
phosphor-DNA-PK to the cytoplasm. Tax-expressing cells harbor significantly increased 
DNA-PK kinase activity, as measured in an in vitro kinase assay. Inhibition of DNA-PK 
activity dramatically reduces Tax-induced autophosphorylation of Chk2, a known DNA- 
PK substrate.
Suppression of DNA-PKcs expression by siRNA has no significant effect on Tax- 
induced G2/M arrest. Tax shows no significant effect on cellular end-joining repair as 
measured by a plasmid-based in vivo end-joining assay. Tax-expressing cells show 
delayed dissolution of damage-induced nuclear speckles containing DNA-PK, y-H2AX 
and Tax, suggesting a mechanism for impaired repair response.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
This dissertation is dedicated to my family, who provided support and encouragement
throughout my studies.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
ACKNOWLEDGMENTS
I would like to thank my committee members, Dr. Julie Kerry, Dr. Ann Campbell 
and Dr. Richard Drake, and especially my adviser Dr. John Semmes for his support in 
conducting my research. I would also like to acknowledge members of my laboratory, 
Dr. Saurabh Gupta and Kimberly Fryrear, who provided technical assistance in many of 
the experiments presented here. In addition, their advice, discussion, and companionship 
were invaluable to me in the completion of this work.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
TABLE OF CONTENTS
Page
LIST OF TABLES...................................................................................................................ix
LIST OF FIGURES...................................................................................................................x
Section
1. INTRODUCTION....................................................................................................1
Human T-Cell Leukemia Virus Type 1 .......................................................1
Cellular Tropism and Viral Entry................................................................ 3
Epidemiology................................................................................................. 3
Diseases of HTLV-1 Infection.....................................................................4
The Tax Oncoprotein.................................................................................... 7
2. SPECIFIC AIMS....................................................................................................15
3. ISOLATION OF TAX-INTERACTING PROTEINS.........................................17
Introduction..................................................................................................17
Experimental Procedures.............................................................................19
Results..........................................................................................................26
Discussion................................................................................................... 38
4. REGULATION OF TAX BY PHOSPHORYLATION..................................... 43
Introduction................................................................................................. 43
Experimental Procedures............................................................................ 45
Results.......................................................................................................... 50
Discussion................................................................................................... 60
5. TAX INTERACTION WITH DNA-PK.............................................................. 68
Introduction................................................................................................. 68
Experimental Procedures............................................................................ 70
Results.......................................................................................................... 78
Discussion....................................................................................................88
6. FUNCTIONAL ROLE OF TAX-DNA-PK INTERACTION........................... 99
Introduction................................................................................................. 99
Experimental Procedures...........................................................................101
Results  ............................................................................................. 104
Discussion..................................................................................................108
7. CONCLUSIONS..................................................................................................113
Summary....................................................................................................113
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
viii
Page
Significance of Findings...........................................................................114
Future Directions.......................................................................................117
REFERENCES...................................................................................................................... 120
APPENDIXES
A. COPYRIGHT PERMISSION............................................................................. 133
B. AUTHORIZATION FOR USE OF
RADIOACTIVE MATERIAL.............................................................................134
VITA.......................................................................................................................................135
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
LIST OF TABLES
Table Page
I. Tax-binding Protein Candidates in Fig.5 Identified
by LC-MS/MS Analysis............................................................................................36
II. Relative Incidence of Phosphorylated Ions................................................................61
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
LIST OF FIGURES
Figure Page
1. Efficient Expression of Tax in a Stable, Inducible Cell Line.................................. 27
2. Affinity Purification of Tax Complex from Stable Cell Line..................................29
3. Identification of Proteins Affinity Purified with HisTaxGFP..................................31
4. Efficient Expression of Biologically Active S-tagged Tax...................................... 32
5. Affinity Purification of S-tagged Tax from Mammalian Cells................................ 35
6. Bioinformatics Analysis o f Tax Interactome.............................................................39
7. Functional Domains and Potential Sites o f Phosphorylation in Tax....................... 51
8. Efficient Expression of Biologically Active Affinity Tagged Tax Protein.............53
9. Tax Phosphopeptide Map............................................................................................55
10. Neutral Loss Ion Map of Non-tryptic Peptide Containing S300/301......................56
11. Mutational Analysis o f Tax Phospho-specific Mutants............................................58
12. Partial MALDI-TOF Spectrum of a Tax Tryptic Digest.......................................... 62
13. Identification of DNA-PK in Tax Complex...............................................................79
14. Induction of Phosphorylated DNA-PKcs by Tax......................................................81
15. Efficient Expression of Tax Deletion Mutants.......................................................... 83
16. Redistribution of DNA-PK by Tax Deletion Mutants............................................  84
17. Tax Activation of DNA-PK Kinase Activity.............................................................87
18. Retention of IR-induced Phosphor-DNA-PK
and y-H2AX Foci by Tax...........................................................................................89
19. Effect of Tax on End-joining Repair........................................................................ 106
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
xi
Figure Page
20. Efficient Suppression of DNA-PKcs by siRNA..................................................  107
21. Cell Cycle Analysis o f Tax-expressing Cells with Reduced DNA-PKcs........... 109
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
1SECTION 1 
INTRODUCTION
Human T-Cell Leukemia Virus Type 1
Human T-Cell Leukemia Virus Type 1 (HTLV-1) was the first human retrovirus 
to be discovered (1,2). Retroviruses are a family of enveloped double-stranded RNA 
viruses that can be divided into two categories—simple and complex—based on the 
organization of their genomes. All retroviruses contain four major coding regions: gag, 
pro, pol, and env (3). Complex retroviruses code for additional regulatory proteins.
Retroviruses carry two copies of the RNA genome encased in a nucleocapsid and 
surrounded by an envelope. In brief, the replication cycle begins with attachment of the 
virion to a cell surface receptor followed by fusion and entry o f the core into the cell. 
The key feature of a retrovirus is reverse transcription of the RNA genome into double­
stranded DNA. This provirus, in association with virion proteins, is transported into the 
nucleus and the viral DNA is integrated into the chromosomal DNA of the cell at more or 
less random sites. The proviral DNA is transcribed by cellular RNA polymerase II. 
Transcripts are processed to become both full-length and spliced messenger RNAs as 
well as full length viral RNA genome. Messenger RNA is translated by cellular 
machinery in the cytoplasm to produce virion proteins. Virion proteins and viral genome 
are assembled and virions are released by budding. Mature virions are produced by 
proteolytic processing of capsid proteins to produce infectious virus. This brief overview 
describes the life cycle of retroviruses, including HTLV-1 (3,4).
This dissertation follows the format of The Journal o f Biological Chemistry.
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2HTLV-1 is a complex retrovirus and a member of the Deltaretroviruses which 
also include Bovine Leukemia Virus (BLV), Simian T-cell Leukemia Virus (STLV), 
HTLV-2, HTLV-3 and HTLV-4. The HTLV-1 genome is 9 kb and, like other 
retroviruses, contains 5’ and 3’ long terminal repeats (LTRs) which contain signals for 
transcriptional control o f viral gene expression (4). In addition to the retroviral gag, pro, 
pol, and env genes, the HTLV-1 genome includes the p X  region encoding unique 
regulatory and accessory proteins (4). The HTLV-1 gag gene encodes 19-kD matrix 
(MA), 24-kD capsid (CA), and 15-kD nucleocapsid (NC) structural proteins (5). The pro 
gene encodes the 14-kD protease which is responsible for processing mature gag products 
(6). The pol gene encodes the 95-kD reverse transcriptase (3). The env gene encodes 
envelope proteins which include the 46-kD surface glycoprotein (SU) and 21-kD 
transmembrane protein (TM) (7). Within the p X  region are overlapping reading frames 
encoding for accessory proteins p l2 !, p l3n and p30n, and regulatory proteins 27-kD Rex 
and 40-kD Tax (8). While the accessory proteins, p i2 1, p l3n and p30n, are not required 
for viral replication in vitro, they may be essential for establishment of persistent viral 
infection in vivo (8). The regulatory proteins, Rex and Tax, however, are essential for 
viral replication, and are involved in regulation of viral expression. Rex is involved in 
controlling gene expression by activating nuclear export of unspliced viral RNA (9). Tax 
is a trans-acting transcriptional activator that regulates transcription from the viral 
promoter as well as certain cellular promoters (10). Many additional functions of Tax 
contribute to the unique pathogenesis o f HTLV-I, which will be discussed in depth 
below.
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3Cellular Tropism and Viral Entry
HTLV-1 preferentially infects CD4+ T-cells in the peripheral blood, however 
infection of other hematopoietic cells, including CD8+ T-cells, may also occur in vivo 
(11,12). Although CD8+ T-cells are infected by HTLV-1, only CD4+ T-cells present a 
pre-leukemic phenotype (13). Viral binding and entry depends upon interaction of the 
HTLV-1 Env receptor with a cellular receptor, the ubiquitous glucose transporter, GLUT- 
1 (14,15). Extracellular virions have very low infectivity, and efficient spread of HTLV- 
1 infection requires cell-to-cell contact (16-18). The virus can induce cell-cell fusion and 
syncytium formation, both of which require envelope glycoproteins (19,20). A study 
using confocal microscopy to examine the cell-to-cell spread of HTLV-1 identified a 
structure at the cell-cell junction termed a ‘virological synapse’ (17). This structure 
describes a virus-induced polarization of the cytoskeleton of the infected cell at the cell­
cell junction, accompanied by accumulation of the HTLV-1 core protein Gag and the 
viral genome at the same site (17). After 2 h, both the Gag protein and viral genome 
were transferred from the infected cell to the uninfected cell (17). The ability o f HTLV-1 
to spread from cell to cell directly without forming extracellular virions may limit its 
exposure to the immune system (16). Further immune evasion may be attributed to a 
latent phase where viral replication occurs not through viral gene expression but via 
persistent clonal expansion o f infected T-cells harboring the integrated viral genome (21).
Epidemiology
There are an estimated 20-30 million people in the world infected with HTLV-1 
(22,23). Studies o f seroprevalence indicate that HTLV-1 is endemic in distinct
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4geographic areas, including Japan, parts of Africa, Central and South America, and the 
Caribbean basin (24-32). In the Caribbean, 3-4% of the population is seropositive for 
HTLV-1 (24); and in Japan, an estimated 1.2 million individuals are HTLV-1-infected 
(25,26). The major modes of viral transmission occur from mother-to-child via 
breastfeeding, intravenously through blood transfusion or injection drug use, or sexually 
(22,24,27-30). In the United States, HTLV-1 infection is found primarily among 
intravenous drug users, sex workers and immigrants from endemic areas (24,31). The 
seroprevalence of HTLV-1 in US blood donors was found to be 0.025% (32). Due to the 
risk of viral transmission through blood transfusion, in November 1988, the Food and 
Drug Administration (FDA) issued recommendations to screen all whole blood donations 
in the United States for HTLV-1 (33). Screening of blood donations for HTLV-1 has 
also been implemented in Japan, Canada, Brazil and several European countries (31).
Diseases of HTLV-I Infection
HTLV-1 infection is linked to two life-threatening and incurable diseases, Adult 
T-cell Leukemia (ATL) and HTLV-1 Associated Myelopathy/Tropical Spastic 
Paraparesis (HAM/TSP), as well as other chronic inflammatory conditions, including 
uveitis, infective dermatitis, polymyositis, bronchioalveolar pneumonitis, auto-immune 
thyroiditis and arthritis (31,34,35).
Adult T-Cell Leukemia
The first link between a retrovirus and a human cancer was demonstrated in 1980, 
when Poiesz et al. discovered a retrovirus in a cell line derived from a patient with
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5cutaneous T-cell lymphoma, and designated it Human T-cell Leukemia Virus Type 1 
(36). In the next two years, the linkage between ATL and HTLV-1 was demonstrated by 
the presence of an antibody against HTLV-1 in sera from a patient with ATL, and the 
finding o f proviral DNA in ATL cell lines (37,38). The following year, the virus was 
molecularly cloned and the complete nucleotide sequence o f the 9 kb proviral genome 
was determined (39).
More than 800 cases o f ATL are diagnosed in Japan each year (25,26). The 
cumulative lifetime risk of an HTLV-1-infected individual developing ATL or HAM/TSP 
is estimated at 2 to 5 percent, and this number increases if the individual has other 
illnesses (23,24,40). Furthermore, there is evidence that co-infection with HTLV-1 and 
Human Immunodeficiency Virus Type 1 (HIV-1) accelerates progression to Acquired 
Immunodeficiency Syndrome (AIDS) (23,41). ATL develops after decades o f chronic, 
latent infection, indicating that the mechanism of T-cell transformation must involve 
multiple, complex events over an extended period of time.
ATL is classified into four clinical subtypes: acute, chronic, smoldering, and 
lymphoma-type, based on disease presentation, progression, and response to treatment 
(42). Acute ATL, comprising 55-75% of all ATL cases, is characterized by fever, cough, 
lymphoadenopathy, skin lesions, hepatosplenomegaly, marked leukocytosis, and 
hypercalcemia frequently associated with lytic bone lesions (22,34). Without treatment, 
ATL is rapidly fatal, often with complications from immunodeficiency, and cause of 
death is frequently from pulmonary complications, opportunistic infections, sepsis or 
uncontrolled hypercalcemia (34).
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6The prognosis of ATL patients is poor. ATL cells are resistant to anti-cancer 
agents, and conventional chemotherapy is ineffective for treating aggressive forms of 
ATL. The median survival time of patients with acute ATL is 13 months, despite 
treatment with the most intensive chemotherapy (43). Other treatment regimens include 
nucleoside analogues, topoisomerase inhibitors, interferon-a, and arsenic trioxide, often 
in combination (44). Other therapies are targeted at inhibiting NF-kB activity, which 
increases transcription of anti-apoptotic genes in ATL cells (45). Monoclonal antibodies 
targeted at cell differentiation markers on the malignant cells provide an alternative 
therapeutic approach (44). Finally, some success has been achieved with the use of 
allogeneic stem cell transplantation following cytoreductive chemotherapy and total body 
irradiation (46).
HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis and Other Diseases
Like ATL, HAM/TSP only occurs in a small percentage of HTLV-1-infected 
individuals, with gradual onset decades after infection (31). HAM/TSP is a 
neurodegenerative disorder characterized by chronic inflammatory changes in the spinal 
cord, with the principle disability being spasticity of the lower legs (34). The 
pathogenesis is thought to be caused by an immunological response to HTLV-1 infection 
(31). Treatment approaches include anti-retroviral drugs, corticosteroids and 
immunosuppressive drugs, and interferon-a immunotherapy, none of which have good 
success (31,34).
Other autoimmune diseases have been associated with HTLV-1-infection, 
including uveitis, infective dermatitis, polymyositis, bronchioalveolar pneumonitis, auto­
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7immune thyroiditis and arthritis (31,34,35). Uveitis is the only HTLV-associated disease 
in which HTLV viral sequences and HTLV-1 infected T-cells have been detected in 
patients (47). The other diseases have only epidemiological evidence of association with 
HTLV-1.
Prevention
Disease prevention relies on public health initiatives aimed at preventing HTLV-1 
infection, including routine screening of blood donations, avoidance of breast-feeding by 
infected mothers, protected sex, and vaccine development. A prototype vaccine 
containing the envelope gene in a live recombinant vaccine provided some protection in a 
rabbit model o f infection (48). Other vaccine development focuses on peptide vaccines 
developed from Tax, naked DNA vaccines, and passive immunization with HTLV-1 
immune serum (49-51). No HTLV-1 vaccine has been tested in clinical trials.
The Tax Oncoprotein
The HTLV-1 Tax protein plays a central role in initiating cellular transformation 
leading to the development of ATL. Tax is a 353 amino acid, 40 kD protein encoded by 
the p X  region of the HTLV-1 genome. While Tax has a predominantly nuclear 
localization, it shuttles between the nucleus and cytoplasm, and has important functions 
in both compartments (52). It specifically localizes to discrete subnuclear foci, 
designated Tax Speckled Structures (TSS) (53). Post-translational modifications o f Tax, 
including phosphorylation, ubiquitination and sumoylation at multiple sites, are an 
important mechanism o f regulation (54-58). Sequence analysis o f Tax and mutagenesis
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experiments have revealed a number of important functional domains including a nuclear 
localization signal (59,60), nuclear export signal (52,61), activation specific region (62), 
leucine zipper-like domains (63,64), dimerization domains (63,65,66), PDZ-domain 
binding motif (67,68), KJX-interacting domain (69-71), and zinc-finger domain (59). 
The Tax protein is widely regarded as a key element in HTLV-1-mediated 
transformation.
Transforming Potential o f Tax
A number of studies have demonstrated the transforming potential o f Tax both in 
vivo and in vitro. Introduction of Tax alone or in combination with Ras in rodent 
fibroblasts transforms cells, which are tumorigenic when injected into nude mice (72,73). 
Tax expression also immortalizes primary human T-cells (74,75). Expression of the tax 
gene in vivo induces tumors in transgenic mice (76-78). Collectively, these observations 
demonstrate a critical role for Tax in HTLV-1-mediated transformation and ATL 
pathogenesis.
In addition to this direct evidence for Tax’s role in transformation, there is a 
tremendous wealth of data demonstrating oncogenic activity of Tax in vitro. 
Oncogenesis can occur through an accumulation of mutations in the cellular genome 
which can be mechanistically attributed to chromosomal instability or loss of DNA repair 
function. Chromosomal instability results in polyploidy and aneuploidy, while loss o f 
DNA repair function results in structurally damaged chromosomes bearing point 
mutations, deletions, substitutions, and translocations. Many of these features are 
demonstrated in HTLV-1-mediated transformation. Aneuploidy is a striking feature of
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ATL cells, which have multilobulated nuclei, commonly referred to as “flower” cells 
(25). Meanwhile, Tax expression alone causes multi-nucleated (polyploid) cells (79,80). 
HTLV-1-transformed lymphocytes derived from patients contain a variety of 
chromosomal abnormalities, including translocations, rearrangements, duplications and 
deletions (81). Chromosomal damage is a characteristic o f Tax-expressing cells, as 
observed by the induction of micronuclei (MN), which represent fragmented 
chromosomes indicative o f DNA damage, or defects in DNA repair or in chromosomal 
segregation (82). Additional evidence of genomic instability comes from a study 
showing a 2.8-fold increase in mutation frequency in mammalian cells expressing Tax 
(83). An increased mutation rate has also been observed in Tax-expressing yeast (84). 
The mutations induced in the presence of Tax are random, suggesting impairment in the 
ability o f the cell to repair accumulated DNA damage introduced during the normal life 
cycle o f the cell (83).
While HTLV-1 can infect both CD4+ and CD8+ T-cells, only CD4+ infected cells 
exhibit a preleukemic phenotype, and this is correlated with evidence of genomic 
instability and Tax expression (85). A study examining the differences between CD4+ 
and CD8+ HTLV-1-infected T-cells demonstrated a high percentage of multinucleated 
cells, chromosomal bridges, and G2/M arrest only in the infected CD4+ T-cell population 
(85). These data suggest that the restriction of the leukemic phenotype to the CD4+ T- 
cell subtype is a result of genomic instability characterized by accumulated cellular 
defects and cell cycle redistribution correlated with Tax expression (13).
Tax-induced genomic instability is attributed to its multiple functional activities; 
however, the exact mechanism is still unknown. In general, as will be discussed below,
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many Tax functions, including transactivation, cell cycle dysregulation and interference 
with DNA repair are dependent on Tax protein-protein interactions with cellular factors. 
Tax activity results in inactivation of cell cycle checkpoints combined with inhibition of 
DNA repair, leading to an accumulation of mutations, and ultimately cellular 
transformation.
Tax Transactivation Functions
While transcriptional activation by Tax allows for regulation of viral transcription 
through its ability to frans-activate the viral long terminal repeat (LTR), this activity also 
allows Tax to influence transcription of key cellular genes. Tax activates the viral LTR 
through three 21-bp repeats known as Tax responsive elements (TxRE) (86). The TxRE 
contains a conserved 8-nucleotide core sequence TGACG(T/A)(C/G)(T/A) that closely 
mimics the consensus cAMP responsive element (CRE; TGACGTCA) (87). The CRE- 
binding protein (CREB) forms an unstable complex with the viral CRE, but is stabilized 
by direct interaction with Tax (88,89). Tax also recruits the co-activators CREB binding 
protein (CBP), p300, and p300/CBP-associated factor (P/CAF) to the complex, where 
they induce chromatin conformational modification at the promoter via histone 
acetylation (10). While Tax has limited direct contact with DNA through amino acid 
residues 89-110, interaction with transcriptional co-activators is required for 
transactivation (90,91). Aside from the viral LTR, Tax can frans-activate or -repress 
numerous cellular genes through direct interaction with CRE, CREB, CBP/p300, P/CAF, 
as well as other CREB/activating transcription factor (CREB/ATF) family members 
(70,92-95).
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Tax also stimulates cellular transcription through activation o f the NF-kB 
pathway via direct binding to the IkB kinase y/NF-xB essential modulator (IKKy/NEMO) 
protein in the cytoplasm, leading to IkB phosphorylation, proteasomal degradation, and 
persistent NF-kB activity (91,96-98). Furthermore, Tax can bind directly to IkBs to 
induce their proteasomal degradation (98,99). Additionally, Tax binds to other NF-kB 
family proteins within the nucleus including NF-kB p50, p65, c-Rel, and NF-kB-2 to 
enhance transcriptional activation of NF-KB-responsive promoters (100). Constitutive 
activation of NF-kB is found in ATL cells as well as in Tax-expressing cells (101-103).
Tax modulates the activity o f the serum response element (SRE) promoter 
through direct interaction with serum response factor (SRF) and the SRF cofactor, ternary 
complex factor (TCF) (104,105). Activation of the SRE promoter by Tax results in 
increased expression of proto-oncogenes c-Fos, cJun, JunB, JunD and Fra-1, which are 
components of transcription factors that regulate the expression o f genes essential for cell 
proliferation, differentiation and prevention of apoptosis (106).
Collectively, Tax-mediated modulation o f transcription via the CREB, NF-kB, 
and SRF pathways leads to up- and down-regulation of a range of cellular genes involved 
in multiple processes. Examples of genes up-regulated by Tax include cytokines and 
receptors such as IL-2 and IL-2Ra, chemokine receptors, proto-oncogenes, cell cycle 
regulators, and anti-apoptotic gene b c l - X L  (34). Tax represses transcription of genes 
including DNA repair enzyme DNA (3 polymerase, DNA topoisomerase I, TGF-pi, and 
pro-apoptotic gene bax (34). Microarray analysis o f transcriptional changes in HTLV-1- 
infected or Tax-expressing cells as compared to normal cells reveals altered expression of
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many genes relevant for maintaining genomic integrity, including those involved in cell 
cycle, DNA repair, and apoptosis (107-111).
Cell Cycle Dysregulation by Tax
The effect of Tax on transcription of genes involved in cell cycle regulation can 
directly contribute to genomic instability. In addition to transcriptional control, Tax 
influences cell cycle regulation through direct interaction with cellular proteins. 
Maintenance of genomic integrity requires precise replication and segregation of 
chromosomes, and impaired cell cycle regulation directly interferes with this process. 
Tax activity, through a combination of transcriptional activation and interaction with 
cellular proteins, results in inactivation of cell cycle checkpoints, including accelerated 
Gl/S progression, impaired G2/M transition, and loss of the mitotic spindle assembly 
checkpoint (80,112-114).
Cell cycle genes transcriptionally regulated by Tax include cyclins A, C, D2 and 
E; cyclin-dependent kinases (CDK) cdk2 and cdk4; CDK inhibitors (CKI) p lS ^ ^ 0, 
p 1 9INK4<i anj  p2 i Wafl/ClP1? p27Kipl; and E2F (115,116). Physical interaction of Tax with 
cellular proteins also promotes dysregulation of the cell cycle. Direct binding of Tax 
with CKI, p l6 INK4a and p l5 INK4b, interferes with the inhibition of Cdk4/6, resulting in 
progression through the Gl/S phase of the cell cycle (117,118). Furthermore, Tax 
physically interacts with Cdk4/6, forming an active complex capable o f phosphorylating 
Rb protein and stimulating the G1 to S transition (119). Direct binding of Tax with Rb 
also targets this protein for proteasomal degradation (120). Along with Rb, the activity of 
another important tumor suppressor protein, p53, is also regulated by Tax. In contrast to
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many other types o f cancers which have mutated p53, p53 is wild-type in HTLV-1 - 
infected cells, although Tax inhibits p53 transcriptional activity (121). Evidence from 
our laboratory shows that Tax inactivation of the p53-mediated Gl/S checkpoint 
promotes cell cycle progression even in the presence of DNA damage (114).
Besides the Gl/S checkpoint, Tax activity can abrogate the G2/M checkpoint 
(80,112,122). Studies in our laboratory have shown that Tax binds directly to Chk2, 
resulting in Chk2 activation/phosphorylation, and causes cells to accumulate in the G2/M 
phase of the cell cycle (112). In addition, Tax impairs mitotic spindle checkpoint 
function through direct binding to mitotic arrest defective protein 1 (MAD1), repressing 
its function and resulting in defective cytokinesis and subsequent aneuploidy (79). 
Aneuploidy may also occur as a result of Tax interaction with APCedc20, leading to 
premature securin degradation and improper chromatid separation (122,123). 
Furthermore, centrosome fragmentation has been attributed to the direct binding of Tax 
with Ran and Ran-binding protein-1 (Ran-BPl) located at the spindle poles (124).
Collectively, these studies demonstrate that transcriptional activation by Tax 
along with direct interaction with cell cycle proteins leads to dysregulation of the cell 
cycle. Defects in cell cycle checkpoints combined with improper chromosome 
segregation caused by Tax effectively promotes loss of genomic integrity.
Tax Interference with DNA Repair
The impairment of cell cycle checkpoints caused by Tax is particularly 
detrimental to the genomic integrity o f the cell when DNA damage occurs. As cells 
move through the cell cycle and replicate their DNA, they naturally acquire spontaneous
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
14
mutations. In a normal cell, the DNA damage response pathway acts to pause the cell 
cycle and allow for proper repair before the mutations are passed on to daughter cells. 
Tax contributes to genomic instability not only through abrogation o f cell cycle 
checkpoints, but there is increasing evidence that Tax interferes with the cellular DNA 
damage response. It does this through transcriptional activation of cellular genes as well 
as through direct protein-protein interactions.
Damaged DNA is repaired through several pathways, including base excision 
repair (BER), nucleotide excision repair (NER), homologous recombination (HR), and 
non-homologous end-joining (NHEJ). Tax represses transcription of P-polymerase, a 
DNA polymerase enzyme involved specifically in DNA repair (125). Meanwhile, BER 
activity is reduced in HTLV-1 virus-transformed cells (126). Tax suppresses NER, 
which correlates with its ability to trans-activate proliferating cell nuclear antigen 
(PCNA) (127). Transcriptional repression of human telomerase (hTert) by Tax may 
inhibit the addition of telomeric repeats to stabilize the ends of double-stranded DNA 
breaks (128,129). Recent evidence suggests that the ability of Tax to induce micronuclei 
is dependent on Ku80, a component of the NHEJ pathway of DNA repair (130). Gene 
expression of NHEJ pathway components, Ku and DNA-PKcs, were shown to be reduced 
in Tax-expressing cells by microarray analysis (108). Studies in our laboratory show Tax 
colocalizes with DNA damage response pathway components, Chk2 and 53BP1, at 
nuclear sites of DNA damage (112). The multiple effects of Tax activity on DNA repair 
pathways in the cell have negative implications for the maintenance of genomic integrity.
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SECTION 2 
SPECIFIC AIMS
Human T-cell Leukemia Virus Type 1 (HTLV-1) is a human transforming 
retrovirus. Cellular transformation of T-cells in HTLV-1-infected individuals can cause 
Adult T-cell Leukemia (ATL), and a neurodegenerative disease, HTLV-1 Associated 
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP). Research shows that cellular 
transformation can be caused by expression of a single viral transactivating protein, Tax. 
Although the specific mechanism is not fully known, it is evident that Tax affects diverse 
cellular processes through direct interaction with various cellular proteins.
Tax may contribute to cellular transformation through induction of genomic 
instability. Increasing evidence from our laboratory indicates that Tax interacts with 
components of the cellular DNA damage pathway. In this study we show that Tax 
specifically interacts with a DNA repair enzyme, DNA-dependent Protein Kinase 
catalytic subunit (DNA-PKcs). Identification and functional analysis o f Tax-interacting 
proteins, especially those involved in cellular DNA damage-response pathways, can bring 
forth new insights into the mechanism of Tax-induced genomic instability. Furthermore, 
a detailed analysis o f the physical structure of Tax is critical to understanding how the 
regulation of this protein affects its function. The objective o f this research is to 
investigate the structural and functional characteristics of Tax complexes. The 
hypothesis o f the research is that Tax interacts with and functionally alters cellular 
proteins involved in the DNA-damage response pathway. This study will make a 
significant contribution to our understanding of how Tax transforms cells.
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The objective o f this proposal will be accomplished by pursuing the following 
specific aims:
Aim 1. Isolate and identify Tax-interacting proteins.
Identification of Tax-interacting proteins is critical to ascertaining the cellular 
processes that Tax has an impact on, including the DNA damage-response pathway. We 
will isolate Tax using a stable, inducible system, as well as a transient expression model, 
followed by purification of Tax complexes. The components of the Tax complex will be 
characterized using both mass spectrometry and molecular techniques. Bioinformatics 
analysis will be used to develop a database o f Tax interactions currently documented in 
the research literature, which can be used for predictive modeling of the Tax interactome. 
Aim 2. Characterize functionally significant phosphorylation sites in Tax.
Physical mapping of the Tax structure is critical for developing an understanding 
of its regulation. Studies have shown that phosphorylation of Tax affects function. First, 
we will physically map the sites o f phosphorylation in the Tax protein using mass 
spectrometry. Then we will use mutational analysis to determine the functional 
significance of these modifications.
Aim 3. Determine the functional significance of the interaction of Tax with DNA-PKcs.
We will examine the biological consequence of the Tax-DNA-PK interaction as it 
relates to genomic instability. We will investigate the effects of Tax on several 
measurable activities of DNA-PK, including kinase activity and DNA damage response. 
We will examine the effect of Tax on end-joining repair. Further, using an assay for 
G2/M arrest, we will determine the functional impact of DNA-PK on Tax-induced 
genomic instability.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
17
SECTION 3
ISOLATION OF TAX-INTERACTING PROTEINS 
Introduction
The transforming retrovirus, Human T-cell Leukemia Virus Type 1 (HTLV-1) is 
the causative agent of two life-threatening and incurable diseases, Adult T-cell Leukemia 
(ATL) and HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP), as 
well as other subneoplastic conditions (25,36,38,131,132). The 40-kDa oncoprotein Tax, 
encoded by HTLV-1, plays a central role in HTLV-1 pathogenesis (115). Importantly, 
Tax promotes cellular transformation through its influence on multiple cellular pathways 
including transcriptional activation, cell cycle control, DNA damage response, signal 
transduction, tumor suppressor function and apoptosis (34,115). The primary function of 
Tax is to regulate HTLV-1 gene expression via trans-activation o f the viral LTR, 
however, Tax can also regulate host gene transcription (10). The activation and 
repression of genes involved in diverse cellular pathways is a significant factor in Tax- 
mediated transformation.
The ability o f Tax to regulate gene expression and influence cellular pathways 
depends upon its protein-protein interactions with diverse host cell factors. The 
transactivation function of Tax is conferred by interaction with cellular transcription 
factors and coactivators, including cAMP responsive element binding protein (CREB), 
CREB-binding protein (CBP) and p300, p300/CBP-associated factor (P/CAF), and 
activating transcription factor (ATF) family members ATF-1, ATF-2, ATF-4 and ATFx 
(98-101,112,139-142). Tax also modulates the activity o f the nuclear factor-KB (NF-kB)
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promoter through interacting directly with IkB kinase y/ NF-kB essential modulator 
(IKKy/NEMO), NF-kB p50, p65, c-Rel, NF-kB-2, mitogen activated kinase kinase 
(MEKK1), and NIK (96-98,100,133-135). Direct binding o f Tax to serum response 
factor (SRF) and ternary complex factor (TCF) mediates activation o f the serum response 
element (SRE) promoter, resulting in increased gene expression of transcription factors 
essential for cell proliferation and prevention of apoptosis, including c-Fos, c-Jun, JunB, 
JunD, and Fra-1 (104,106). Microarray analysis of transcriptional changes induced by 
Tax reveals a broad range of affected genes involved in such critical cellular processes as 
cell cycle control, DNA repair response, and apoptosis induction (108,109).
In addition to transcriptional activity, Tax can influence many cellular processes 
through direct protein-protein interactions. Tax has several structural domains important 
for mediating protein-protein interactions including a PDZ domain-binding motif (PBM) 
and coiled-coil domain-binding motif (68,136). The interaction between Tax and PDZ 
domain-containing proteins such as the discs large (Dig) tumor suppressor has been 
associated with the transforming activity of Tax in a colony formation in soft agar 
(CFSA) assay (137). Another domain in Tax is responsible for interacting with a set of 
proteins containing a coiled-coiled motif, a conserved structure for protein-protein 
interaction, and this Tax domain is implicated in the interaction with the spindle assembly 
checkpoint protein MAD1, the centra somal protein TXBP121, and a nuclear transcription 
factor for regulation of cell growth and proliferation, TXBP151 (136). Considering the 
range o f cellular activities influenced by Tax through its interaction with host cell factors, 
it is of great interest to identify new Tax-binding proteins.
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Here, we have attempted to define Tax-interacting proteins in the mammalian 
cell. We have designed a stable, inducible Tax expression system as well as a transient 
expression model to purify Tax complexes from human cell lines. Our approach relies on 
isolating Tax complexes from cells and identifying the cellular components using liquid 
chromatography tandem mass spectrometry (LC-MS/MS). Using this method, we have 
identified the novel Tax-binding protein, the catalytic subunit o f the DNA-dependent 
Protein Kinase (DNA-PKcs), a key enzyme in the DNA damage response pathway. 
Finally, we have conducted a large-scale bioinformatics analysis to generate a digital 
library containing interactions between HTLV-1 Tax and cellular proteins.
Experimental Procedures
Plasmids
The tax-Egfp fusion was originally cloned in frame with a 6XHis tag in pcDNA4. 
HisTaxGFP was subcloned using restriction digestion with Aflll and Notl into a plasmid 
with a tetracycline-responsive DNA element, pcDNA5/FRT/TO/TOPO (Invitrogen, 
Carlsbad, CA).
The S-tagged expression vectors STaxGFP, STax, and SGFP were constructed by 
PCR amplification of the tax-EGFP fusion, tax, or EGFP ORF respectively, using Pfu 
Turbo DNA polymerase (Stratagene, La Jolla, CA) to produce an insert with blunt ends 
which was subcloned into the Smal site o f pTriEx4-Neo (Novagen, Madison, WI) in 
frame with the amino-terminal S-tag and His-tag and a thrombin cleavage site.
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Cell Culture and Generation o f Stable Cell Line
293T cells were maintained at 37°C in a humidified atmosphere of 5% CO2 in air, 
in Iscove’s modified Dulbecco’s medium supplemented with 10% fetal bovine serum 
(Cambrex, East Rutherford, NJ) and 1% penicillin-streptomycin (Invitrogen, Carlsbad, 
CA).
The Flp-In TREx 293 cell line (Invitrogen), which contains a Flp recombination 
target (FRT) site in its genome, was maintained in Dulbecco's modified Eagle's medium 
(DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (Cambrex, East 
Rutherford,NJ), 1% penicillin-streptomycin (Invitrogen), 2 mM L-glutamine (Invitrogen), 
200 pg/mL zeocin (Fisher Scientific, Hampton, NH), and 15 pg/mL blasticidin S (ICN 
Biomedicals, Irvine, CA). To establish a tetracycline-inducible system in 293 cells, 
pcDNA5/FRT/TO vectors encoding HisTaxGFP and pOG44 vector (Invitrogen), which 
expresses Flp recombinase, were cotransfected at a molar ratio of 1:9 into Flp-In TREx 
293 cells using Lipofectamine 2000 reagent (Invitrogen), according to the manufacturer's 
protocol. 48 h post-transfection, 50 pg/mL hygromycin B (Invitrogen) was added to the 
culture for selection. After 2 weeks, hygromycin-resistant cells were harvested and 
pooled together for further analysis. The stable Flp-In TREx 293-HisTaxGFP cells were 
maintained in DMEM supplemented with 10% Tet System Approved fetal bovine serum 
(Clontech, Mountain View, CA), 1% penicillin-streptomycin, 2 mM L-glutamine, 15 
pg/mL blasticidin S, and 50 pg/mL hygromycin B. Expression of HisTaxGFP was 
induced by incubation of cells with 1 pg/mL tetracycline (Fisher, Hampton, NH) for 24 h.
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Transient Transfection
Transfections o f 293T cells were performed by standard calcium phosphate 
precipitation. Cells were plated at lxlO5 cells/mL. The following day, plasmid DNA in 
2M CaCb and 2X HBS were added dropwise to cells in fresh medium. Cells were 
incubated at 37°C for 5 h to overnight and fresh medium was added. The cells were 
harvested 48 h post-transfection, following a single wash with IX PBS, in 500 pi M-Per 
mammalian protein extraction reagent (Pierce, Rockford, IL) with protease inhibitor 
cocktail (Roche, Palo Alto, CA) and immediately frozen at -80°C.
Metal Affinity Protein Purification
Prepared cell lysate (1.5 mL) in M-Per with EDTA-free protease inhibitor cocktail 
(Roche, Palo Alto, CA), was incubated with 100 pi pre-equilibrated Talon Metal Affinity 
Resin (Clontech, Mountain View, CA) and incubated for 30 min rotating at room 
temperature, then washed 3 times with 1 mL IX Equilibration/Wash Buffer (50 mM 
sodium phosphate, 300 mM NaCl, pH 7.0). Washed beads were eluted in IX Imidazole 
Elution Buffer (50 mM sodium phosphate, 300 mM NaCl, 150 mM imidazole, pH 7.0). 
An equal volume of Laemmli Sample Buffer (Bio-Rad, Hercules, CA) with (3- 
mercaptoethanol was added to the eluate, followed by boiling for 5 min. Samples were 
electrophoresed in a 10% SDS polyacrylamide gel and visualized by SilverQuest silver 
staining (Invitrogen, Carlsbad, CA). Bands of interest were manually excised from the 
gel for further analysis.
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S-tag Protein Purification
Prepared cell lysate (1.5 mL) was incubated with 75 pi bed volume of S-protein 
agarose (Novagen, Madison, WI) for 30 min rotating at room temperature, then washed 3 
times with 1 mL Bind/Wash Buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% 
TritonX-100). Washed beads were eluted by resuspension in 150 pi Laemmli Sample 
Buffer (Bio-Rad, Hercules, CA) with P-mercaptoethanol, followed by boiling for 5 min. 
Eluates were electrophoresed in a 10% SDS polyacrylamide gel and visualized by 
SilverQuest silver staining (Invitrogen, Carlsbad, CA). Bands of interest were manually 
excised from the gel for further analysis.
LC-MS/MS Analysis
Protein bands were excised from 1-D polyacrylamide gels. Gel slices were cut 
into 1-2 mm cubes; washed 3X with 500 pL ultra-pure water and incubated in 100% 
acetonitrile for 45 minutes. The material was dried in a speed-vac, rehydrated in a 12.5 
ng/pL modified sequencing grade trypsin solution (Promega, Madison, WI) and 
incubated in an ice bath for 40-45 min. The excess trypsin solution was then removed 
and replaced with 40-50 pL of 50mM ammonium bicarbonate, 10% acetonitrile, pH 8.0 
and the mixture was incubated overnight at 37°C. Peptides were extracted 2X with 25 pi 
50% acetonitrile, 5% formic acid and dried in a speed-vac. Digests were resuspended in 
20 pL Buffer A (5% acetonitrile, 0.1% formic acid, 0.005% heptafluorobutyric acid) and 
3-6 pL were loaded onto a 12-cm x 0.075 mm fused silica capillary column packed with 
5 pM diameter C-18 beads (The Nest Group, Southboro, MA) using a N2 pressure vessel 
at 1100 psi. Peptides were eluted over 55 minutes, by applying a 0-80% linear gradient
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of Buffer B (95% acetonitrile, 0.1% formic acid, 0.005% heptafluorobutyric acid) at a 
flow rate of 130 pL/min with a pre-column flow splitter resulting in a final flow rate of 
~200 nl/min directly into the source. In some cases the gradient was extended to 150 
minutes to acquire more MS/MS spectra. A LCQ™ Deca XP (ThermoFinnigan, San 
Jose, CA) was run in an automated collection mode with an instrument method composed 
of a single segment and 4 data-dependent scan events with a full MS scan followed by 3 
MS/MS scans o f the highest intensity ions. Normalized collision energy was set at 30, 
activation Q was 0.250 with minimum full scan signal intensity at 5 x 105 and a minimum 
MS2 intensity at 1 x 104. Dynamic exclusion was turned on utilizing a three minute 
repeat count of 2 with the mass width set at 1.50 Da. Sequence analysis was performed 
with TurboSEQUEST™ (ThermoFinnigan, San Jose, CA) or MASCOT (Matrix 
Sciences, London, GB) using an indexed human subset database o f the non-redundant 
protein database from National Center for Biotechnology Information (NCBI) web site 
(http://www.ncbi.nlm.nih.gov/). An additional database was created containing only the 
ORF sequence for the expressed Tax protein.
Immunoblot Analysis
Cell extracts were derived as described above. Total protein concentrations were 
determined by Protein Assay (Bio-Rad, Hercules, CA). An equal volume of Laemmli 
sample buffer (Bio-Rad, Hercules, CA) with P-mercaptoethanol was added to the lysate, 
boiled for 5 min, and a normalized amount o f total protein was loaded in each lane and 
electrophoresed through a 10% SDS-polyacrylamide gel. The proteins were transferred 
onto an Immobilon-P (Millipore, Billerica, MA) membrane using a Trans-blot SD semi­
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dry transfer cell (Bio-Rad, Hercules, CA) at 400 mA for 50 min in transfer buffer (25 
mM Tris, 200 mM glycine, 20% methanol, 0.1% SDS). Following blocking in 5% non­
fat milk in PBS/0.1% Tween-20, blots were incubated in primary antibody overnight, 
followed by 1 h incubation in secondary horseradish-peroxidase conjugated anti-mouse 
or anti-rabbit antibody (Bio-Rad, Hercules, CA). Immunoreactivity was detected via 
Immunstar enhanced chemiluminescence protein detection (Bio-Rad, Hercules, CA).
Immunoprecipitation
Whole cell lysate (~2 mg) in 500 pi volume were incubated with 5 pi anti-Tax 
pep3 polyclonal antibody at 4°C overnight, with constant rotation. The lysate was then 
incubated with 100 pi Protein A Sepharose beads (Zymed, San Francisco, CA) while 
rotating for 1 h at 4°C. The beads were washed 3X with 1 mL each IX SNNTE buffer 
(5% sucrose, 500 mM NaCl, 1% Nonidet P-40, 50mM Tris-HCl [pH 7.4], 5 mM EDTA). 
Proteins were eluted from beads with 100 pi Laemmli sample buffer (Bio-Rad, Hercules, 
CA) with P-mercaptoethano 1, and boiled for 5 min.
Fluorescent Microscopy
293T cells were seeded onto 22-mm diameter coverslips in 6-well plates at lxlO5 
cells/well. Transfections were performed as described above, and 48 h later cells were 
washed twice with PBS and fixed in 4% paraformaldehyde. Coverslips were mounted on 
glass slides in Vectashield containing DAPI (Vector Laboratories, Burlingame, CA). 
Fluorescent images were acquired using a Zeiss LSM 510 confocal microscope at 40X
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magnification with a 2.8X zoom using Argon (488 nm) and HeNe2 (633 nm) lasers, and 
imaged with LSM Image Browser software (Carl Zeiss, Jena, Germany).
Luciferase Assay
293T cells, plated at 2x105 cells per well o f a 6-well plate, were transfected as 
described with 1 to 5 pg of Tax expression plasmid, and 1 pg of HTLV-LTR-Luc reporter 
plasmid. The parental vector used for Tax expression, pTriEx4-Neo (Novagen, Madison, 
WI), was added to normalize for the total amount of transfected DNA. Luciferase 
activity was measured 48 h after transfection. Cells were washed twice with IX PBS and 
then lysed in IX Reporter Lysis Buffer (Promega, Madison, WI) and subjected to one 
freeze-thaw at -80°C. Luciferase assay substrate was used according to the 
manufacturer’s protocol, and activity was measured in a TD-20/20 luminometer (Turner 
Designs, Sunnyvale, CA). Luciferase activity was normalized for total cell protein 
determined from whole cell extracts by Protein Assay (Bio-Rad, Hercules, CA), 
according to manufacturer’s direction.
Bioinformatics Analysis
The Human Virus Interactome Resource (HVIR), including a Tax-interaction map 
and digital library of Tax-interacting cellular proteins, was generated as part of a 
collaboration o f Dr. O. John Semmes and Sarah Durkin with a research group at Old 
Dominion University led by Dr. Alex Pothen, Dr. Mohammad Zubair, Dr. Kurt Maly and 
Dr. Chris Osgood, and including Emad Ramadan, Mahmoud Abu-Elela, Khaled Ibrahim, 
and Praveen Namburi. Databases used for bioinformatics analysis were from the
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
26
following public websites: PubMed, www.ncbi.nlm.nih.gov/PubMed/; Yale Medical 
Library, www.med.yale.edu/library/; Human Protein Reference Database, www.hprd.org; 
Database o f Interacting Proteins, dip.doe-mbi.ucla.edu; and Biomolecular Interaction 
Network Database, www.bind.ca.
Results
Efficient Expression o f Tax in a Stable, Inducible Cell Line
In order to isolate cellular proteins that interact with Tax in vivo, we created a 
tandem affinity-tagged Tax construct that could be stably expressed in a human cell line, 
and purified in a complex with cellular binding proteins. Human embryonic kidney 293 
(HEK293) cells were chosen as the parental cell line due to the characteristics o f high 
transfection efficiency and immortality which are advantageous for construction of a 
stable cell line. We have previously demonstrated that Tax has measurable activity in 
this cell line (data not shown). A stable cell line provides an efficient method to harvest 
large numbers o f cells expressing Tax protein. The Flp-In System (Invitrogen) allows for 
stable integration o f the tax gene into a specific genomic location in the host cell chosen 
for optimal protein expression via recombinase-mediated DNA recombination. Tax 
expression is under the control of a tetracycline-responsive promoter, such that uninduced 
cells can be passaged without expression of Tax. This is advantageous because the Tax 
protein can induce cellular toxicity when expressed continuously. The HisTaxGFP 
vector expresses full-length Tax protein fused to amino-terminal His6- and Xpress tags 
and carboxy-terminal green fluorescent protein (GFP) (Fig. I A). The His6 tag, which has 
metal-binding properties, is included for purification using immobilized metal affinity
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His Xpress Tax GFP HisTaxGFP
His Xpress GFP HisGFP
B
-Tet + Tet
HisTaxGFP
F ig . 1. Efficient expression of Tax in a stable, inducible cell line. A, a
depiction of HisTaxGFP and control HisGFP expression vector constructs. B, induction 
of HisTaxGFP expression in Flp-In TREx 293-HisTaxGFP cells by incubation of with 1 
pg/ml tetracycline for 24 h. Left panel shows uninduced cells. C, Flp-In TREx 293- 
HisTaxGFP cells harvested 24 h after induction of HisTaxGFP with the indicated 
concentrations of tetracycline were subjected to immunoblot analysis and probed with 
anti-Xpress antibody (Invitrogen). Cell lysate from 293T cells transiently transfected 
with HisTaxGFP was loaded as a control in the lane marked C.
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resin. The HisGFP vector is used as a control for nonspecific binding in the purification 
scheme (Fig. L4). We included the GFP subunit to facilitate monitoring of protein 
expression and localization, and the Xpress tag to monitor the purification process. We 
efficiently expressed Tax from the Flp-In TREx 293-HisTaxGFP cell line by induction 
with 1 pg/ml tetracycline for 24 h (Fig. 1, B and C). Tax expression is undetectable by 
either fluorescence microscopy or immunoblot analysis in the absence of tetracycline 
(Fig. 1, B and C).
Affinity Purification o f Tax Complex from Stable Cell Line
We successfully purified His6-tagged Tax protein from induced Flpln TREx 293- 
HisTaxGFP cells using immobilized metal affinity resin as described in Experimental 
Procedures. The majority o f Tax protein was captured on the resin, as the flowthrough 
shows minimal Tax protein (Fig. 2A, lane 2), and minimal Tax protein was lost in the 
wash steps (Fig. 2A, lanes 3 and 4). Tax protein is not completely removed from the 
beads in a single elution step, as an almost equal amount is removed in a second elution 
step (Fig. 2A, lanes 5 and 6). Combined, the Tax protein from two elution steps equals 
roughly 10% of the input (Fig. 2 A, compare lane 1 showing 5% input to lanes 5 and 6).
In order to identify cellular proteins bound to Tax protein, we purified 
HisTaxGFP from the stable cell line and resolved the Tax complex by SDS-PAGE 
followed by visualization of the proteins by silver staining (Fig. IB). Control cell lysates 
from 293 cells transiently transfected with HisGFP vector were purified in parallel and 
used as a control for non-specific binding to the metal affinity resin. There is 
considerable non-specific binding, and the most obvious unique band is HisGFP in the
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F ig . 2. Affinity purification of Tax complex from stable cell line. A, cell 
lysate from tetracycline-induced Flp-In TREx 293-HisTaxGFP cells (input) was 
incubated with immobilized metal affinity resin. Following incubation, resin was 
centrifuged and supernatant was removed (flowthrough); resin was washed twice and 
each wash was removed (1st wash, 2nd wash)-, bound protein was eluted twice with 
Laemmli Sample Buffer (Ist elution, 2nd elution). Reserved fractions were subjected to 
immunoblot analysis and probed with anti-Tax polyclonal antibody. B, cell lysates from 
tetracycline-induced Flp-In TREx 293-HisTaxGFP cells (HisTaxGFP) and 293T cells 
transiently transfected with control HisGFP (HisGFP) were subjected to SDS-PAGE and 
proteins were visualized by silver staining.
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control lane (Fig. 2B, lane 2). Using LC-MS/MS, we were able to successfully identify 
the proteins in 8 bands from a gel with HisTaxGFP isolated from the stable cell line (Fig. 
3). One band was identified as Tax. Several of the bands were identified to contain 
chaperonin-containing TCP1 protein, however, in subsequent experiments this protein 
was shown to be present in purifications from both HisTaxGFP- and HisGFP-expressing 
cells, suggesting that TCP1 is binding non-specifically to the metal affinity resin (data not 
shown). The high background of non-specific binding using this method prompted us to 
change to a different type of tag for the purification scheme.
Efficient Expression o f Biologically Active S-tagged Tax
We sought to utilize a more specific affinity purification tag to decrease the non­
specific binding we saw with the metal affinity resin. We chose the S-tag purification 
system (Novagen), which is based on the strong interaction between a 15-amino acid S 
tag and S protein immobilized on agarose beads, both of which are derived from RNase S 
(138). We designed vectors expressing Tax with an amino-terminal S-tag (STax) or with 
an additional carboxy-terminal GFP tag to monitor transfection efficiency and protein 
localization (STaxGFP), and a control S-tagged GFP (SGFP) (Fig. 44). An amino- 
terminal His6-tag is included in all three vectors for tandem affinity purification and to 
facilitate monitoring of protein purification. An additional feature of this vector is a 
thrombin cleavage site located between the S-tag and the protein of interest (Fig. 4A, 
indicated by arrow). This design allows affinity binding of the S-tagged protein to the 
beads followed by thrombin cleavage of the tag to release the protein, rather than elution.
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LC-MS/MS data:
Band Protein Identification
PR04-050
PR04-056
PR04-057
PR04-055
PR04-051
PR04-052
PR04-053
PR04-054
PR04-50 Putatitve pre-mRNA splicing factor 
RNA helicase
PR04-56 WD repeat-containing protein 1, 
isoform 1
Paraspeckle protein 1 alpha 
isoform
PR04-57 Chaperonin-containing TCP1 
Splicing factor 3a 
Unknown protein
PR04-55 Chaperonin-containing TCP1
54 kDa nuclear RNA- and DNA- 
binding protein
PR04-51 Chaperonin-containing TCP1 
MAD homolog 5
PR04-52 Tax [HTLV-1]
PR04-53 Pyrroline-5-carboxylate synthetase
PR04-54 Carbonic anhydrase II inhibitor
Fig. 3. Identification of proteins affinity purified with HisTaxGFP. Cell 
lysate from tetracycline-induced Flp-In TREx 293-HisTaxGFP cells was subjected to 
SDS-PAGE and proteins were visualized by silver staining. Individual bands, indicated 
by arrows, were manually excised from gel and assigned identification numbers 
(indicated), and analyzed by LC-MS/MS. Identified proteins from each band are listed 
with the corresponding band identification number.
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His S-Tag Tax
j k
His S-Tag GFP
STaxGFP
STax
SGFP
B
F ig . 4. Efficient expression of biologically active S-tagged Tax. A, a depiction 
of the STaxGFP, STax, and control SGFP expression vector constructs. B, 293T cells 
were transiently transfected with STaxGFP (green), fixed with 4 % paraformaldehyde, 
permeabilized with methanol and nuclei were stained with DAPI and TOPRO-3-iodide 
(blue). Fluorescent images were acquired with a Zeiss LSM 510 confocal microscope at 
40X magnification using Argon (488 nm) and HeNe2 (633 nm) lasers and imaged with 
LSM Image Browser software. C, 293T cells were cotransfected with the HTLV-I LTR 
Luc reporter plasmid and increasing amounts of either Tax-expressing vector TEX or 
STaxGFP. Luciferase activity is shown as fold activation over non-Tax expressing cells.
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The advantage of this method is that only the protein o f interest along with interacting 
proteins will be removed from the beads by cleavage of the tag, whereas elution will 
release all proteins—specific and non-specific—bound to the beads.
The STaxGFP vector was transiently transfected into 293T cells, and the 
transfection efficiency and appropriate subcellular localization to Tax Speckled 
Structures (TSS) was confirmed by visualizing the GFP expression (Fig. 4B). In order to 
determine whether the S-tagged Tax-GFP fusion protein retains functional activity, we 
compared it to untagged Tax expressed from the IEX  vector in trans-activation assays. 
293T cells were cotransfected with the HTLV-1 LTR Luciferase reporter plasmid and 
either Tax-expressing vector IEX  or STaxGFP. STaxGFP showed comparable 
transcriptional activity to untagged Tax (Fig. 4C). The activity of STaxGFP as measured 
by the ability to activate via the NF-KB-responsive promoter and to induce cell cycle 
accumulation in 4N was also comparable to untagged Tax (data not shown). Thus we 
showed that S-tagged Tax protein is biologically active and efficiently expressed in 
mammalian cells. Although the Flp-In TREx 293-HisTaxGFP stable cell line produces 
Tax protein in every cell, the protein expression of STaxGFP is much higher per cell and 
therefore overall expression of STaxGFP is higher than the stable cell line, even though it 
is a transient transfection. Therefore, we found this to be an efficient method for 
expressing Tax in mammalian cells.
Affinity Purification o f S-tagged Tax from Mammalian Cells
We successfully purified S-tagged Tax protein from transiently transfected 293T 
cells using S-protein agarose beads as described in Experimental Procedures. The eluted
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protein from the affinity purification was further resolved by SDS-PAGE and the STax 
and control SGFP proteins were detected by blotting with S-protein HRP-conjugate (Fig. 
5A). Silver staining of a gel with STaxGFP and SGFP affinity purifications allowed 
visualization of interacting proteins (Fig. 5, B and C). Distinct bands corresponding to 
the predicted molecular weight of SGFP and STaxGFP are labeled (Fig. 5, B and C, 
arrows), indicating purification of a large quantity of S-tagged protein. Unlike the metal 
affinity purification process, the S-tag purification method produces limited non-specific 
binding, apparent in the presence of only one major band in the control SGFP lane which 
is also present in the STaxGFP lane (Fig. 5, B and C, open arrow).
Identification o f Tax-interacting Proteins
Using LC-MS/MS, we successfully identified the proteins in 9 bands of a gel 
containing purified STaxGFP complexes from transiently transfected mammalian cells 
(Table I). Several o f the bands contained Tax, and the lower molecular weight bands 
presumably contain Tax degradation products. The non-specific band present in the 
control SGFP lane (Fig. 5, B and C, open arrow) was identified as Raichu404X. 
Significantly, we identified a novel Tax-interacting protein, the catalytic subunit o f the 
DNA-dependent Protein Kinase (DNA-PKcs), a key enzyme in the cellular response to 
DNA damage. Confirmation of this interaction and investigation of the functional 
significance is addressed in subsequent sections of this dissertation.
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F ig . 5. Affinity purification of S-tagged Tax from mammalian cells. Cell 
lysates from 293T cells transiently transfected with SGFP, STax, or STaxGFP (indicated) 
were affinity purified on S-protein agarose beads as described under “Experimental 
Procedures” and subjected to SDS-PAGE and analysis using S-protein HRP-conjugate 
(Novagen) (A) or silver staining (B  and C). Individual bands were manually excised from 
the silver stained gels (B  and C), assigned identification numbers (indicated), and 
subjected to LC-MS/MS analysis (Table I).
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T a b l e  I
Tax-binding protein candidates in Fig. 5 identified by LC-MS/MS analysis
Band Protein identification
PRO-189 P-actin
Tax [HTLV-1]
Unknown protein
F-box only protein 22 iso form a
PRO-190 Unknown protein
Euk. Translation initiation factor 4a
PRO-191 P 5-tubulin
Unnamed protein product 
Tax [HTLV-1]
Raichu404X
Vimentin
Ribonuclease/angiogenin inhibitor
PRO-192 Tax [HTLV-1] 
Raichu404X 
P 5-tubulin
PRO-193 Tubulin alpha 6 
Tax [HTLV-1] 
Raichu404X 
ATP synthase, subunit
PRO-194 Raichu404X 
Tax [HTLV-1]
TCP1, chaperonin, Hsp60 
KIAA0002
PRO-195 Tax [HTLV-1]
PRO-196 Tax [HTLV-1]
PRO-231 DNA-activated protein kinase, catalytic subunit
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Bioinformatics Analysis
In addition to using experimental approaches to identify novel Tax-interacting 
proteins, we undertook a bio informatics approach to categorize documented Tax 
interactions and provide a framework for predicting potential interactions. In 
collaboration with a research group at Old Dominion University, we built the Human 
Virus Interactome Resource (HVIR), designed as a digital library of Tax-interacting 
proteins. Furthermore, HVIR provides an interactive tool for researchers to visualize 
documented Tax-interacting proteins as well as ‘second neighbors’ o f Tax, or binding 
partners o f Tax-interacting proteins. This provides information to guide experiments in 
the laboratory which can determine if  the ‘second neighbors’ are also in the Tax complex. 
Thus, HVIR provides a useful tool for predicting protein-protein interactions.
A database of known Tax-interacting proteins was created by extracting relevant 
information from selected journal articles in the online medical literature, using well- 
established text mining approaches. The extracted information was normalized and 
represented in a standardized format based on the Biomolecular Interactions Network 
Database (BIND) XML prototype, and stored in the HVIR digital repository. The quality 
of the text-mining data was validated manually by researchers. Several protein 
interaction databases available on public websites, including BIND, Human Protein 
Reference Database (HRPD), and Database of Interacting Proteins (DIP), were used as 
sources of information about ‘second neighbors’ of Tax. Finally, a network-drawing 
program was used for visualizing the Tax interactome network, and to present an 
interactive search service for the user. Clustering algorithms are also being developed to 
predict functional modules, protein complexes, and pathways from the proteomic
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network. A schematic diagram indicating the workflow of HVIR development is 
included (Fig. 6A).
While development of the Tax interactome resource is still in progress, a current 
model incorporates 82 direct interacting proteins identified from selected journal articles, 
in addition to countless ‘second neighbors’ identified via protein interaction databases, 
(data not shown). Interestingly, by examining the network for relevant ‘second 
neighbors’ o f Tax, the interaction of Tax and DNA-PKcs presented here could have been 
predicted based on a range of common binding partners (Fig. 6B). For example, Tax 
interacts with NFKB1, whose activity is regulated by IKK alpha, a phosphorylation target 
of DNA-PK (91,139). Another DNA-PK phosphorylation target is p53, a binding partner 
of 53BP1, which Tax also interacts with (112,140). The interaction could have been 
predicted through Chk2, a Tax-interacting protein that associates with mediator o f DNA 
damage checkpoint protein 1 (MDC1), which interacts with DNA-PK (112,141-143). 
Collectively, this depiction of the Tax interactome predicts the presence of DNA-PKcs in 
the Tax complex.
Discussion
We used affinity purification to identify cellular proteins that interact with Tax in 
mammalian cells. Using a stable, inducible Tax expression system, we successfully 
purified His6-tagged Tax protein with metal affinity resin. However, this method 
produced unsatisfactory levels of non-specific protein binding. Consequently, we 
developed a transient expression system for affinity purification of S-tagged Tax protein
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Fig. 6. Bioinformatics analysis of Tax interactome. A, a schematic diagram of 
Human Virus Interactome Repository (HVIR) development. B, a schematic display of a 
subset of interactions in the Tax-DNA-PK network, as identified by HVIR. Tax and 
DNA-PK are indicated, along with additional interacting proteins.
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with S-protein beads. This process allowed us to efficiently purify Tax complexes from 
mammalian cells with limited non-specific binding to the beads. Protein-protein 
interactions account for many of the pleiotropic functions of Tax, and identification of 
novel cellular binding partners contributes to our understanding of how this oncoprotein 
induces genomic instability and transformation.
Using affinity purification, we identified the DNA damage response protein, 
DNA-PKcs, as a novel Tax-interacting protein. Previous studies in our laboratory and 
others have identified other components of the DNA damage response pathway that 
interact with Tax. Tax physically interacts with Chk2, and co-localizes with both Chk2 
and 53BP1 in nuclear Tax Speckled Structures (TSS) (112,143). The Tax-Chk2 
interaction promotes delayed progression through the G2/M checkpoint (112). Tax 
further impacts the DNA repair pathway through transcriptional activation and repression 
of key repair proteins, including P-polymerase and proliferating cell nuclear antigen 
(PCNA) (125,127,144). Base excision repair (BER) activity is reduced in HTLV-1 
transformed cells and Tax suppresses nucleotide excision repair (NER) (114,126,127). 
Dysregulation o f DNA repair by Tax can contribute to genomic instability (145). Thus, 
the interaction of Tax with DNA repair factor, DNA-PKcs, may influence the 
maintenance of genomic integrity.
DNA-PK is the key enzyme in the non-homologous end joining (NHEJ) pathway 
of DNA double strand break (DSB) repair (146-149). It is a nuclear serine/threonine 
kinase consisting of an approximately 470 kDa catalytic subunit (DNA-PKcs) and a 
regulatory subunit composed of the Ku70 and Ku86 heterodimer. Based on structural 
homology, DNA-PKcs belongs to a family o f protein kinases known as
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phosphatidylinositol 3-kinase-like protein kinases (PI3KK), which includes DNA damage 
response proteins, ATM and ATR. The kinase activity of DNA-PKcs is stimulated by 
physical association with double-strand DNA. Along with playing a key role in DNA 
repair via NHEJ, DNA-PK is also involved in other important responses to DSBs, 
including cell cycle arrest and apoptosis (148). A further role for DNA-PK has been 
shown in maintaining telomeres to prevent them from being recognized as DSBs. In fact, 
in the absence of DNA-PK, cells exhibit telomeric fusions and increased chromosomal 
instability (150). DNA-PK is thus critically involved in many important cellular 
responses to DNA damage and maintenance of genomic integrity. The interaction o f Tax 
with DNA-PK may have deleterious effects on the cell, and is the subject of further 
investigation in our laboratory.
Our bio informatics analysis o f reported studies identifying Tax interactions 
combined with information from protein interaction databases led to development o f the 
Human Virus Interactome Resource (HVIR). Current work is focused on increasing the 
search for Tax-interacting proteins via text-mining, and developing search and 
visualization methods for accessing and analyzing the data. Using the current model of 
the Tax interactome as presented in Fig. 6, we demonstrated that the interaction between 
Tax and DNA-PKcs could have been predicted using HVIR. A careful analysis o f 
documented Tax interactions along with ‘second neighbor’ interactors using this resource 
could reveal many more members o f the Tax complex. While there are many available 
databases documenting cellular protein interactions, HVIR provides the first digital 
library containing interactions between proteins from viruses and humans. A manual 
search of PubMed reveals over 1200 publications on the topic o f HTLV-1 Tax, with more
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added daily. Efficient evaluation of this literature to determine the complete network of 
Tax interactions requires automated processes. We chose to use a text-mining approach 
to collect these data, and then present it in a way that can be analyzed to address the 
functional significance of the Tax interactome. Combining this Tax network with 
information from available databases about cellular protein interactions gives a more 
complete picture of the impact of Tax on the cellular proteome. These data are 
invaluable for understanding the multiple pleiotropic functions of Tax. HVIR can 
provide researchers with a valuable tool to guide experimentation in the search for novel 
Tax interactions which contribute to its function.
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SECTION 4
REGULATION OF TAX BY PHOSPHORYLATION 
Introduction
Human T-cell Leukemia Virus Type 1 (HTLV-1) is a human transforming 
retrovirus. Infection with HTLV-1 can give rise to Adult T-cell Leukemia (ATL), 
HTLV-1 Associated Myelopathy/Tropical Spastic Paraperesis (HAM/TSP) as well as 
other subneoplastic conditions (25,131,151-153). Although cellular transformation can 
be achieved by expression of a single viral transactivating protein, Tax, the exact 
mechanism of transformation is not known (115). Tax is thought to induce genomic 
instability and thus contribute to cellular transformation through interaction with cellular 
proteins involved in cell cycle control and the DNA damage repair response 
(112,114,128,130,145). In addition, Tax can activate or repress a variety o f cellular 
genes predominately through the CREB and NF-kB pathways (115,154). Thus, 
uncovering the regulatory mechanism for controlling the various Tax activities is critical 
to understanding HTLV-1-mediated cellular transformation.
There have been several structure-function studies of the Tax protein 
predominately utilizing molecular biology techniques. Specifically, with respect to the 
regulation of multiple Tax activities it has been noted that mutation or deletion of 
individual domains results in a selective loss o f function (155). Important domains for 
Tax function include a nuclear localization signal (60,155), nuclear export signal (52,61), 
activation specific region (62), two leucine zipper-like domains (63,64), and a zinc-finger 
domain (59). Mutation o f a number of individual serine residues in Tax have been shown
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to alter its ability to trans-activate either CREB or NF-kB responsive promoters (155). In 
addition to phosphoryl-specific post-translational modifications, recent studies have 
uncovered an important regulatory role for ubiquitin/sumoyl-modifications (54,57). 
Clearly, Tax structural domains contribute to its regulation.
Phosphorylation is a common reversible regulatory event with a central role in 
controlling frans-acting/transcription (156). Earlier studies have demonstrated that Tax is 
a phosphoprotein (157) and that phosphorylation can regulate Tax activation of the 
HTLV-1-LTR (158,159). We conducted the first attempt toward identification of Tax 
phosphorylation sites using a scanning serine to alanine substitution mutational analysis. 
This study identified that substitution of serine residue at position 10 or 274 resulted in a 
Tax mutant which lost the ability to transactivate both CREB and NF-kB responsive 
promoters (155). A separate study showed that serine to alanine substitution at Tax 
amino acid 77 significantly reduced transactivation of a CREB-dependent promoter 
(160). However, 2-D mapping of tryptic fragments suggested that this site is not 
phosphorylated in vivo. Using tryptic peptide analysis, Bex et al. (1999) identified Tax 
phosphorylations on two serine residues at positions 300 and 301, and showed that they 
are critical for transcriptional activation by Tax. While the role o f phosphorylation in the 
regulation of Tax is important, a complete map of the sites of phosphorylation within Tax 
has not been reported.
New methods for affinity purification and liquid chromatography tandem mass- 
spectrometry (LC-MS/MS) allow for direct interrogation of the presence of phosphoryl 
residues (161). In this study, we combined LC-MS/MS analysis of affinity purified Tax 
protein with a substitution mutational analysis to identify and functionally characterize
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phosphorylation sites. The LC-MS/MS analysis achieved 77% coverage of the Tax 
sequence and identified four novel sites o f phosphorylation on serine and threonine 
residues. Phosphorylation at specific amino acid residues provided both positive and 
negative regulatory signals. These results highlight the importance of phosphorylation in 
the regulation of Tax activity.
Experimental Procedures
Mammalian Expression Plasmid
The S-tagged expression vector STaxGFP was constructed by inserting the tax- 
EGFP fusion ORF into the Smal site o fpTriEx4-Neo (Novagen, Madison, WI) in frame 
with the amino-terminal S-tag and His-tag.
Cell Culture and Transfection
293T cells were maintained at 37°C in a humidified atmosphere of 5% CO2 in air, 
in Iscove’s modified Dulbecco’s medium supplemented with 10% fetal bovine serum and 
1% penicillin-streptomycin (Invitrogen, Carlsbad, CA). Jurkat cells were maintained in 
RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin- 
streptomycin (Invitrogen, Carlsbad, CA).
Transfections o f 293T cells were performed by standard calcium phosphate 
precipitation. Cells were plated in 150-mm plates at 4x106 cells per plate. The following 
day, 20 pg of plasmid DNA in 2M CaCL and 2X HEPES-buffered saline were added 
dropwise to cells in fresh medium. Cells were incubated at 37°C for 5 h and fresh 
medium was added. The cells were harvested 48 h later, following a single wash with IX
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PBS, in 500 pi M-Per mammalian protein extraction reagent (Pierce, Rockford, IL) with 
protease inhibitor cocktail (Roche, Palo Alto, CA) and immediately frozen at -80°C.
Transfections o f Jurkat cells were performed by electroporation with Bio-Rad 
Gene Pulser II with Capacitance Extender (Bio-Rad, Hercules, CA). lxlO7 cells were 
electroporated with 30 pg HTLV 1 LTR Luc reporter vector and 30 pg Tax plasmid in 
250 pi RPMI with 10% fetal bovine serum in 0.2 cm electrode gap cuvette at 280 V and 
960 pF. Following electroporation, cells were resuspended in 5 mL complete media. 
The cells were harvested 48 h later for luciferase assays in Reporter Lysis Buffer as 
described below.
Purification o f Tax Protein
Prepared cell lysate (1.5 ml) was incubated with 75 pi bed volume o f S-protein 
agarose (Novagen, Madison, WI) for 30 min at room temperature, then washed 3 times 
with 1 mL Bind/Wash Buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% TritonX- 
100). Washed beads were eluted by resuspension in 150 pi Laemmli Sample Buffer 
(Bio-Rad, Hercules, CA) with P-mercaptoethanol, followed by boiling for 5 min. Eluates 
were electrophoresed in a 10% SDS-polyacrylamide gel and visualized by Coomassie 
Blue staining. Bands of interest were manually excised from the gel for further analysis.
Immunoblot Analysis
Cell extracts were derived as described above. Total protein concentrations were 
determined by Protein Assay (Bio-Rad, Hercules, CA). A normalized volume of 
Laemmli sample buffer (Bio-Rad, Hercules, CA) with P-mercaptoethanol was added to
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the lysate, boiled for 5 min, and a normalized amount of total protein was loaded in each 
lane and electrophoresed through a 10% SDS-polyacrylamide gel. The proteins were 
transferred onto an Immobilon-P (Millipore, Billerica, MA) membrane by semi-dry 
electroblotting and probed with anti-GFP monoclonal antibody (Santa Cruz 
Biotechnology, Santa Cruz, CA) and secondary horseradish-peroxidase conjugated anti­
mouse antibody (Bio-Rad, Hercules, CA). Immunoreactivity was detected via Immunstar 
enhanced chemiluminescence protein detection (Bio-Rad, Hercules, CA).
LC-MS/MS Analysis
Protein bands were excised from SDS-polyacrylamide gels. Gel slices were cut 
into 1-2 mm cubes; washed 3X with 500 pL Ultra-pure water and incubated in 100% 
acetonitrile for 45 minutes. The material was dried in a speed-vac, rehydrated in a 12.5 
ng/pL modified sequencing grade trypsin solution (Promega, Madison, WI) and 
incubated in an ice bath for 40-45 min. The excess trypsin solution was then removed 
and replaced with 40-50 pL of 50mM ammonium bicarbonate, 10% acetonitrile, pH 8.0 
and the mixture was incubated overnight at 37°C. Elastase digestion was performed as 
described for trypsin at an enzyme concentration of 15 ng/pL without acetonitrile in the 
reaction buffer. Peptides were extracted 2X with 25 pi 50% acetonitrile, 5% formic acid 
and dried in a speed-vac. Digests were resuspended in 20 pL Buffer A (5% acetonitrile, 
0.1% Formic Acid, 0.005% heptafluorobutyric acid) and 3-6 pL were loaded onto a 12- 
cm x 0.075 mm fused silica capillary column packed with 5pM diameter C-18 beads 
(The Nest Group, Southboro, MA) using a N2 pressure vessel at 1100 psi. Peptides were 
eluted over 55 minutes, by applying a 0-80% linear gradient of Buffer B (95%
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acetonitrile, 0.1% formic acid, 0.005% heptafluorobutyric acid) at a flow rate of 130 
pL/min with a pre-column flow splitter resulting in a final flow rate of ~200 nl/min 
directly into the source. In some cases the gradient was extended to 150 minutes to 
acquire more MS/MS spectra. A LCQ™ Deca XP (ThermoFinnigan, San Jose, C A ) was 
run in an automated collection mode with an instrument method composed of a single 
segment and 4 data-dependent scan events with a full MS scan followed by 3 MS/MS 
scans of the highest intensity ions. Normalized collision energy was set at 30, activation 
Q was 0.250 with minimum full scan signal intensity at 5 x 105 and a minimum MS2 
intensity at 1 x 104. Dynamic exclusion was turned on utilizing a three minute repeat 
count of 2 with the mass width set at 1.50 Da. Sequence analysis was performed with 
TurboSEQUEST™ (ThermoFinnigan, San Jose, CA) or MASCOT (Matrix Sciences, 
London, GB) using an indexed human subset database of the non-redundant protein 
database from National Center for Biotechnology Information (NCBI) web site 
(http://www.ncbi.nlm.nih.gov/). An additional database was created containing only the 
ORF sequence for the expressed Tax protein.
MALD1-TOF Analysis
Tryptic digests of purified Tax protein were resuspended in 20 pL 70% 
acetonitrile, 0.1% formic acid and 2 pL applied to a MP384 steel MALDI target (Brucker 
Daltonics, Bilaricka, MA). Spectra were acquired in reflectron mode using 96.3 pjoules 
laser power at 20 Hz with a total shot count of approximately 500.
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Site-Directed Mutagenesis
Site-directed mutagenesis was performed using QuikChange II (Stratagene, La 
Jolla, CA) site-directed mutagenesis kit to introduce single amino acid changes by 
altering one or two nucleotides at the mutation site in the STaxGFP template. Both 
forward and reverse primers were designed to contain the desired mutation according to 
the manufacturer’s protocol. Methylated original STaxGFP plasmid derived from 
bacteria was used as the template, and mutagenic primers were extended with PfuUltra 
high-fidelity DNA polymerase during a 16-cycle PCR, incorporating the desired mutation 
into newly synthesized strands. The remaining methylated template was digested with 
the Dpnl provided, and the PCR product was used to transform XL-1 Blue competent 
bacteria. Bacterial colonies growing under ampicillin selection were selected for further 
processing and correct plasmids were purified using the Qiagen Maxiprep system 
(Qiagen, Valencia, CA). Introduction of each mutation was confirmed by DNA sequence 
analysis (Davis Sequencing, Davis, CA), and expression was confirmed by transfection 
and western analysis using anti-GFP monoclonal antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA).
Luciferase Assays
293T cells, plated at 2x105 cells per well o f a 6-well plate, were transfected as 
described with 2 to 8 pg of Tax expression plasmid, and 1 pg of HTLV-LTR-Luc or pNF- 
k B -L u c  (Clontech, Mountain View, CA) reporter plasmid. The parental vector used for 
Tax expression, pTriEx4-Neo (Novagen, Madison, WI), was added to normalize for the 
total amount o f transfected DNA. Luciferase activity was measured 48 h after
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transfection. Cells were washed twice with IX PBS and then lysed in IX Reporter Lysis 
Buffer (Promega, Madison, WI) and subjected to one ffeeze-thaw at -80°C. Luciferase 
assay substrate was used according to the manufacturer’s protocol, and activity was 
measured in a TD-20/20 luminometer (Turner Designs, Sunnyvale, CA). Luciferase 
activity was normalized for total cell protein determined from the whole cell extracts by 
Protein Assay (Bio-Rad, Hercules, CA), according to manufacturer’s direction.
Results
Functional Domains o f HTLV-1 Tax
As a reference point for structure-fimction determination, we present a composite 
representation of known functional domains o f HTLV-1 Tax protein in Fig. 7. The 
specific sites/motifs were assembled from a manual search o f the peer-reviewed 
literature. The potential phosphorylation sites at S10 and S274 were mapped based on 
substitution mutation analysis from our earlier studies (155). The S77 site was defined 
via 2-D mapping of tryptic fragments (160). Serine residues 300 and 301 have been 
previously identified as sites o f phosphorylation by combined tryptic peptide and 
substitution mutational analysis (55). None of the previous studies utilized mass 
spectrometry and the physical mapping of the S3 00/301 tryptic peptide did not formally 
rule out phosphorylation at four possible alternative sites that are predicted to reside in 
the same tryptic fragment.
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Fig. 7. Functional domains and potential sites of phosphorylation in Tax.
Tax contains a nuclear localization signal (NLS) (155) and a nuclear export signal (NES) 
(61). Domains for binding CREB, SH3, p300/CBP, IKKy, LIM, P/CAF, and PDZ are 
indicated (64,68,71,162). Tax contains multiple leucine zipper-like regions and an 
activation specific domain (62-64). Other regions are necessary for CREB2 contact and 
DNA contact (90,163). Also shown are the Zn-finger domain, and domains required for 
dimerization and NF-kB activation (59,66,164). Potential sites of phosphorylation at 
serine residues 10, 77, and 274 are indicated (155,160). Serine residues 300 and 301 
have been previously identified as sites o f phosphorylation (55).
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Expression o f  Biologically Active Affinity-tagged Tax Protein
In order to facilitate the analysis o f phosphopeptides in the Tax protein occurring 
in vivo, we created a tandem affinity tagged Tax construct that could be expressed in and 
purified from mammalian cells. The STaxGFP vector expresses full-length Tax protein 
fused to amino-terminal 6XHis- and S-tags, and carboxy-terminal green fluorescent 
protein (GFP) (Fig. SA). We included the GFP subunit to facilitate protein expression 
and purification monitoring. The STaxGFP vector was transiently transfected into 293T 
cells, and the transfection efficiency and appropriate subcellular localization to Tax 
Speckled Structures (TSS) was confirmed by visualizing the GFP expression (Fig. 8C). 
In order to determine whether the tandem affinity tagged Tax-GFP retains functional 
activity, we compared it to untagged Tax expressed from the IEX  vector in trans- 
activation assays. 293T cells were cotransfected with the HTLV-I LTR Luc reporter 
plasmid and either Tax-expressing vector IEX  or STaxGFP. STaxGFP showed 
comparable transcriptional activity to untagged Tax expressed from the IEX  vector (Fig. 
4Q . The activity of STaxGFP as measured by the ability to activate via NF-kB- 
responsive promoter and to induce cell cycle accumulation in 4N was also comparable to 
wild type Tax (data not shown). Thus efficient expression of functionally active tagged 
Tax was achieved in mammalian cells.
Affinity Purification o f Tax from Mammalian Cells
We successfully purified S-Tagged Tax protein from transfected 293T cells using 
S-protein agarose beads as described in the methods section. The purification is based on
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Fig. 8. Efficient expression of biologically active affinity tagged Tax protein.
A, a depiction of the STaxGFP expression vector construct. B, affinity purification of S- 
tagged Tax from mammalian cells. 293T cells were transfected with STaxGFP, purified 
on S-protein agarose beads, eluted and resolved by SDS-PAGE, and detected by 
Coomassie staining. C, 293T cells were transiently transfected with STaxGFP (speckles), 
fixed with 4% paraformaldehyde, permeabilized with methanol and stained nuclei with 
TOPRO-3-iodide (Molecular Probes, Eugene, OR). Fluorescent images were acquired 
with a Zeiss LSM 510 confocal microscope at 40X magnification using Argon (488 nm) 
and HeNe2 (633 nm) lasers and imaged with LSM Image Browser software (Carl Zeiss, 
Jena, Germany).
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the strong interaction between the 15 amino acid S-Tag and S-protein immobilized on 
agarose beads, both of which are derived from RNase S (165). The eluted protein from 
the affinity purification was further resolved by SDS-PAGE and a distinct STaxGFP band 
was detected by Coomassie blue staining (Fig. SB). This process produced sufficient 
quantities o f highly purified Tax protein from mammalian cells and allowed for the 
subsequent post-translational modification analysis by LC-MS/MS.
Phosphopeptide Mapping o f Tax using LC-MS/MS
We employed several strategies in determining the phosphorylation sites in Tax. 
First, the purified STaxGFP protein was subjected to enzymatic digestion by trypsin 
resulting in approximately 15 peptides within the reproducible dynamic mass range of the 
ion trap accounting for nearly 50% of the sequence. Tryptic peptides that were too large 
to detect were either further digested with elastase or independently digested with 
elastase, resulting in an additional 27% sequence coverage. The combined analysis o f all 
of the peptide fragments generated by digestion with either trypsin or elastase enabled us 
to obtain a detailed physical map covering 77% of the Tax sequence (Fig. 9A). We found 
only suggestive evidence that the previously reported S300/301 was phosphorylated (55). 
Specifically, of the 23 experimental runs conducted only a single instance of a base peak 
neutral loss from a non-tryptic peptide was found indicating a phosphate residing on 
either S300 or S301, but not both (Fig. 10). There was no evidence for phosphorylation 
at S10, S77 or S274.
We next employed a directed chemical derivatization of serine or threonine 
residues in order to rule out poor ionization efficiency or lability o f the phosphates at
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Fig. 9. Tax phosphopeptide map. A, a compilation of the results obtained with 
LC-MS/MS analysis of Tax. The identified phosphorylation sites are indicated (bold). 
The Tax amino acid sequence assessed by enzymatic digestion with trypsin (solid line) 
and/or elastase (dotted line) is marked. The total analyzed sequence is highlighted. The 
inserted table shows % total amino acid, serine amino acids and threonine amino acids 
coverage of LC-MS/MS analysis. B, the novel phosphorylation sites and the 300/301 site 
are shown with the appropriate Tax sequence.
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Fig. 10. Neutral loss ion map of non-tryptic peptide containing S300/301.
MS/MS spectrum of a phosphorylated base peak ion indicating a loss of HPO3 from the 
+3 parent ion. The inset shows the resulting matched ion series for the selected peptide. 
The database search was conducted without an enzyme restriction against the Tax-GFP 
sequence.
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S300/301 (166). This approach utilizes a P-elimination/ethanediol addition which results 
in phosphoserine and phosphothreonine conversion to the more stable S-ethylcystein or 
P-methyl-S-ethylcystein respectively. These derivatives are then detected by an increase 
of 44 amu from the unmodified serine or threonine residues. This method failed to 
increase the incidence rate o f the S300/301 phosphorylation event suggesting that the low 
incidence is not an artifact of ionization but rather indicative o f native abundance. 
Results from the combined analysis detected three phosphothreonine residues at positions 
48, 184 and 215, and two phosphoserine residues at positions 300/301 and 336 (Fig. 9B).
Mutational Analysis o f the Identified Tax Phosphorylation Sites
Tax trans-activates viral and cellular gene expression through either the 
ATF/CREB or N F -kB  activation pathways (60,155,167). Thus, we evaluated each 
substitution mutation for trans-activation activity via both CREB-dependent and N F -kB -  
dependent promoters. Tax mutants were transiently co-transfected into 293T cells with 
either HTLV-1 LTR Luc or N F -kB  L uc reporter plasmid to assay for the ability of Tax to 
activate either the ATF/CREB or N F -kB  pathways, respectively. To determine the 
possible regulatory role of phosphorylation at the specific sites determined by mass 
spectrometry, single amino acid substitutions were introduced at T48>A, T48>D, 
T184>A, T184>D, T215>A, T215>D, S300/301>A, S300/301>D, S336>A and S336>D. 
The stability o f the expressed protein containing the specific substitution mutations was 
determined by Western blot analysis (Fig. 1I A). These data were also used to normalize 
the extracts for the biological assays.
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kDa 
75-
50 -
B % WT ACTIVITY
CLONE TESTED HTLV-ILTR Luc NF-kB Luc
STaxGFP 100 100* 100
T48>A 71 67* 32
T48>D 51 32* 2
T184>A 96 63
T184>D 87 80
T215>A 71 68* 89
T215>D 8 28* 10
S300/301>A 15 18* 13
S300/301>D 73 165* 20
S336>A 84 110
S336>D 80 98
Fig. 11. Mutational analysis of Tax phospho-specific mutants. A,
immunblot analysis of the expression of Tax mutants in cells compared to wild type 
Tax-expressing cells. 10 pg of wild type STaxGFP DNA (STaxGFP) or 20 pg of 
mutant STaxGFP DNA (indicated) was transfected into 293T cells. Equal amounts 
of whole cell lysate were loaded on the gel, and blotted with anti-GFP antibody. B, 
tra«s-activation assay. 293T cells were co-transfected with either the HTLV-I LTR 
Luc or the NF-kB L uc reporter plasmid (indicated), and vectors expressing either 
wild-type STaxGFP (STaxGFP) or a Tax mutant (indicated). The specific amino 
acid substitution for each Tax mutant is shown. Luciferase activity is shown as a 
percentage of the activity relative to wild-type Tax. In some experiments (indicated 
by an asterisk) Jurkat cells were used to analyze activation of HTLV-I LTR Luc 
plasmid. The values presented are the median of replicate measurements with an 
average CV of 0.083 (CV range from 0.012 to 0.2)
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
59
The results o f the fra/is-activation assays are shown in Fig. 11B. Substitution mutations 
at T184 and S336 showed only a slight reduction in activity although each o f these sites 
is clearly phosphorylated. Substitutions at T48 had a more pronounced effect upon NF- 
kB activity than was measurable via CREB activation. Interestingly, the T48>A 
mutation retained both CREB and NF-kB activation when compared to the 
phosphomimetic substitution T48>D. This result implies that phosphorylation at this site 
provides a negative regulatory signal. Likewise, Tax T215>A retained full activity in 
both assays where as the phosphomimetic substitution T215>D was inactive for each 
assay suggesting that phosphorylation at this site results in significant decrease o f both 
Tax activities. Examination of the S300/301 substitution mutations confirmed a previous 
report that S300/301>A retains only partial activity for either NF-kB or CREB activation 
and the phosphomimetic substitution S300/301>D specifically recovers the CREB 
activity but not the NF-kB activity (55). To determine whether the functional activity of 
these mutants is retained in a cell type targeted by HTLV-1, we tested mutants in 
luciferase assays measuring transactivation of HTLV-1 LTR in Jurkat cells (Figure 11R). 
We found that those mutants with significant differences in functional activity from wild 
type showed the same pattern of activity in both 293T cells and Jurkat cells.
Semi-quantitation o f Phosphorylated Tax Protein
Although not directly quantitative it is possible to evaluate the stoichiometric 
relationship between phosphorylated and unphosphorylated protein by determining the 
frequency that a phosphoryl-peptide is detected. We re-examined all spectra of sufficient 
quality to identify Tax phosphopeptides and counted the relative incidence of
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phosphorylated ions versus all ions arising from the same sequence. The results of this 
analysis are shown in Table II. The establishment of an absolute percentage of the 
peptide form is not reliable through this method; however a general conclusion can be 
drawn that the majority of Tax is phosphorylated at T48 and S336. In addition a minor 
but significant portion of the protein is phosphorylated at T 184 and T215.
The much broader dynamic mass range of MALDI-TOF allowed analysis of 
tryptic peptides too large for the ion trap, such as the 40 amino acid tryptic peptide 
containing S300/301. In addition, since ion acquisition is temporally static and devoid of 
data-dependent activation, MALDI-TOF analysis facilitates ion counting for semi­
quantitation of modified peptides. We were able to easily observe several of the large 
predicted tryptic masses corresponding to unmodified/modified peptides as well as the 
most abundant Tax-specific ionic masses seen with the ion trap instrument. MASCOT 
searches o f these peak lists yielded identification of Tax as well as the GFP fusion 
protein, confirming that the predominant analyte was our fusion protein. We conducted 5 
identical experiments and compared the relative average area under each of the peaks to 
obtain an estimate of <5% of all peptides were phosphorylated. An example of the 
spectral trace from one experiment is shown in Fig. 12. All of the resolvable features 
were consistent with a single phosphorylation event. Thus, our data suggests that 
phosphorylation of Tax at S300/301 occurs at a single site and is a rare event.
Discussion
The oncoprotein, Tax, encoded by the Human T-cell Leukemia Virus Type 1 
(HTLV-1), is implicated in viral pathogenicity through its multiple pleiotropic functions.
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T a b l e  II
Relative incidence o f phosphorylated ions
Amino
acid Sequence
Ion
Ratio1 %P2
T48 HALLATYPEHQITWDPIDGR 23/23 100%
T184 FLTNVPYKRIEEL 4/11 36%
S336 EADDNDHEPQISPGGLEPPSEK 17/21 81%
T215 ISLTTGALIILPEDCLPTTLFQPAR 4/13 31%
High quality spectra from 23 experimental runs were examined for the presence of 
indicated ions.
'ion ratio is the number of times the phosphoryl-ion was detected over the total number 
o f times any ion was detected.
2Percent o f phosphorylated ions was determined by solving the ion ratio formula.
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Fig. 12. Partial MALDI-TOF spectrum of a Tax tryptic digest. Peptide 
masses equivalent to the phosphorylated and non-phosphorylated tryptic peptide 
containing S300/301 are shown. Area under the curve was calculated from the total 
isotopic distribution of each peptide. This spectrum represents the highest percentage of 
phosphorylated S300/301 peptide observed in five separate experiments.
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While this transacting factor is essential for effective viral replication through its ability 
to activate viral transcription, Tax can also activate and repress transcription o f a variety 
of cellular genes. This process occurs through targeting of both the CREB and NF-kB 
pathways. In addition, there have been many models proposed in which Tax interacts 
with cellular proteins, to promote cellular transformation via dysregulation of the cell 
cycle, inhibition o f tumor suppressor proteins, and modulation of the DNA damage repair 
response (100,145). The specific regulation of all or a subset of these activities 
represents the functional impact o f Tax on cell proliferation, increased mutation rate, and 
ultimately cellular transformation and leukemogenesis. Clearly then, a complete 
understanding of Tax-mediated oncogenesis is dependent upon a better understanding of 
how the activities o f the protein are regulated.
As a central molecular regulatory mechanism, phosphorylation has been shown to 
modulate transcription factor function by multiple mechanisms including regulation of 
DNA binding, cellular localization, protein-protein interactions and protein stability 
(168). Examples can be found in the scientific literature of both positive and negative 
regulation of transcription factors by phosphorylation. Regulation o f transcription factor 
DNA binding activity may be negatively regulated due to the introduction of a negative 
charge within or nearby a DNA binding domain, generating electrostatic repulsion with 
the phosphates on the DNA and thus inhibiting DNA binding (168,169). In other cases, 
the phosphorylation sites are located distal to the DNA binding domain, and regulation of 
DNA binding is mediated via phosphorylation-induced alteration in protein 
conformation. An example of negative regulation of DNA binding by distal site 
phosphorylation has been described for the transcription factor c-myb, in which
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phosphorylation at sites ~50 residues from the DNA-binding domain inhibit transcription 
factor docking (169). The DNA binding activity of the transcriptional repressor, Wilms’ 
tumor gene product WT1, is similarly inhibited by phosphorylation within a distal zinc- 
finger region (168,170). Sometimes phosphorylation of transcription factors regulates 
transactivation function via post-binding mechanisms. For example, phosphorylation of 
yeast transcription factor ADR1 does not affect DNA binding activity, but instead 
negatively regulates the interaction with general transcriptional machinery and thus 
controls transactivation function (171).
Given the preponderance of regulatory mechanisms involving phosphorylation, 
there have been some efforts directed at determining the role o f phosphorylation in the 
regulation of HTLV-1 Tax. The first investigation, resulting in the determination that 
the native protein was phosphorylated predominately on serine, utilized two-dimensional 
thin layer chromatography and tryptic peptide analysis (24). Subsequently, we conducted 
a mutational analysis o f Tax protein that targeted all 47 serine residues (155). This study 
was followed by a combined mutational analysis and 2-D mapping o f Tax tryptic 
fragments (160). Neither of these studies could conclusively identify functionally 
relevant phosphorylation sites within Tax. However, Bex et al identified a specific 
phosphorylation of serine residues 300/301 by reverse-phase high-performance liquid 
chromatography o f Tax tryptic fragments (55). These investigators also employed 
substitution analysis directed at amino acids 300 and 301 to demonstrate that “active” 
Tax protein required phosphorylation at this site. However, there were several theoretical 
scenarios, such as phosphorylation at other sites within the same tryptic fragment and 
dual phosphorylation at 300/301, which were not formally ruled out. In our current
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study, we report the phosphorylation of Tax at four novel sites; threonine residues 48, 
184, and 215, and serine residue 336, as well as confirming the phosphorylation at either 
serine residue 300 or 301. One explanation for why the other phosphorylation sites were 
not identified in this earlier study may be that the HPLC fractionation procedure may 
have resulted in a loss o f other phosphopeptides in the protein. The selective loss of 
phosphopeptides can result from the addition of a phosphate group thus reducing 
hydrophobicity which may cause it to fail to be retained on the reversed-phase material 
used in purification (172). An additional consideration is that this study analyzed Tax 
protein derived from BHK21 (hamster kidney) cells, which may produce alternative post- 
translational modification patterns when compared to human cells. Although not without 
it’s own limitations, our approach provides a more robust method for the comprehensive 
mapping of phosphorylation sites (161,172-174). We were able to identify 
phosphorylated Tax peptides as well as assign the sites of phosphorylation to specific 
residues by peptide sequencing using tandem mass spectrometry. Contrary to previous 
reports, however, our studies show that Tax is predominantly phosphorylated on 
threonine residues.
In addition to the dominance of threonine phosphorylation, we identified 
phosphorylation sites that were found to be negative regulators of Tax activity. 
Specifically, while alanine substitution at threonine residues 48 or 215 resulted in Tax 
mutants that retained the ability to activate gene expression, substitution with the 
phosphomimetic aspartic acid residue resulted in a dramatic loss o f activity. For 
threonine residue 48, this effect was more pronounced for activation of the NF-kB 
pathway than the CREB pathway. Although the Tax protein was abundantly
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phosphorylated at threonine residue 184 and serine residue 336, the mutational analysis 
revealed no significant effect on the ability of Tax to activate gene expression. This 
result is consistent with the known existence of functionally silent phosphorylation 
events.
One logical model for our combined results is that phosphorylation at either S300 
or S301 along with dephosphorylation at T48 and T215 confers an activation state for 
Tax. A second aspect of our analysis allowed for inference toward the relative 
stoichiometry of individual phosphorylation events by determining the relative 
abundance of specific ions across 23 separate experiments. This summarization clearly 
suggested that phosphorylation at S300 or S301 was a rare event and that 
phosphorylation at T48 and T215 was a common event. Thus, “active” Tax protein, 
which is phosphorylated at S300/301 and dephosphorylated at both T48 and T215, is less 
abundant than “inactive” Tax protein. The fact that the active/inactive ratio of a 
biologically potent oncoprotein is skewed toward the inactive state has significant impact 
upon modeling Tax function. Hypothetically then, function of Tax with respect to 
promoter activation requires phosphorylation at S300 or S301. Additionally, selective 
activation of CREB-dependent promoters is achieved by phosphorylation at T48 and 
dephosphorylation at T215. Thus, discrete regulation of the pleiotropic functionality 
displayed by the Tax oncoprotein may be reflected in variations o f its phosphorylation 
pattern. This variation is likely dependent upon the host cell type as well as the specific 
cellular physiological environment. The combined role of Tax post-translational 
modifications, including phosphorylation, as we have discussed here, and
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ubiquitination/sumoylation as has been discussed elsewhere (54,57,58,175), provide a 
wealth of signals controlling protein structure, stability and localization.
In silico analysis o f the sequence surrounding the identified phosphorylation sites 
in Tax, using ELM (http://elm.eu.org) and MotifScan (http://scansite.mit.edu), revealed 
several consensus sites for kinase recognition. Serine 336 is located within a proline- 
dependent serine/threonine kinase consensus motif, and threonine 48 is located within a 
casein kinase 2 consensus motif. Our data suggests that phosphorylation at T48 results in 
loss of the ability to transactivate via the NF-kB pathway. Thus, casein kinase 2 activity 
may provide an important regulatory signal for Tax-mediated activation of the NF-kB 
pathway. This phosphorylation site lies within the zinc-finger domain of Tax, and may 
represent a negative regulatory mechanism similar to that described for WT1 (170). 
Future studies will be aimed at uncovering the kinetic relationship of Tax post- 
translational modifications and Tax function.
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SECTION 5 
TAX INTERACTION WITH DNA-PK 
Introduction
The human transforming retrovirus, Human T-cell Leukemia Virus Type 1 
(HTLV-1) is the causative agent of Adult T-cell Leukemia (ATL), HTLV-1 Associated 
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) as well as other subneoplastic 
conditions (25,36,38,131,132). Cellular transformation can be caused by expression of a 
single viral transactivating protein, Tax (115). Although the specific mechanism is not 
fully known, it is evident that Tax affects diverse cellular processes through direct 
interaction with various cellular proteins involved in cell cycle control and DNA damage 
repair response (112,114,115,128,130,145). This activity is thought to induce genomic 
instability, thus contributing to cellular transformation. Identification and functional 
analysis o f Tax-interacting proteins is therefore critical to understanding the mechanism 
by which Tax induces genomic instability.
Studies showing increased mutation frequency in both Tax-expressing 
mammalian cells and yeast provide evidence of genomic instability induced by Tax 
(83,84). These mutations are o f a random nature, suggesting impairment of the ability of 
the cell to repair accumulated DNA damage introduced during its normal life cycle (83). 
Furthermore, an increase in DNA breaks is observed in Tax-expressing cells as 
micronuclei (MN), which seem to occur not due to a Tax-induced increase in DNA strand 
breaks, but due to Tax-induced loss o f cellular DNA repair function (128,145). The cell 
has a variety o f mechanisms to repair damaged DNA including base excision repair
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(BER), mismatch repair (MMR), and non-homologous end-joining (NHEJ). Tax 
represses transcription of ^-polymerase, an enzyme involved specifically in BER, and 
BER is suppressed in HTLV-1-transformed cells (125,126). Tax also suppresses NER, 
which correlates with its ability to trans-activate proliferating cell nuclear antigen 
(PCNA) (114,127). Transcriptional repression of human telomerase (hTert) by Tax may 
inhibit the addition of telomeric repeats to stabilize the ends o f double-strand DNA 
breaks (128,129). In addition, a reduction or loss of expression of two or more MMR 
genes was observed in primary leukemic cells from 11 patients with ATL (176). There is 
further evidence that the ability o f Tax to induce micronuclei is dependent on Ku80, a 
component of the NHEJ pathway of DNA repair (130). Microarray analysis showed that 
Ku80 gene expression is reduced in Tax-expressing cells (108). Still other effects of Tax 
were demonstrated by studies in our laboratory and others which show that Tax 
physically interacts with the DNA damage pathway protein Chk2 (112,143). Tax co- 
localizes with both Chk2 and 53BP1 at nuclear sites of DNA damage (112). Collectively, 
these studies demonstrate the wide-ranging effects Tax has on the capacity of the cell to 
appropriately respond to DNA damage.
In this study, we identified a novel physical interaction between Tax and DNA- 
dependent Protein Kinase (DNA-PK), an important regulator of the cellular response to 
double-strand DNA breaks (DSBs). We show that Tax co-localizes within nuclear Tax 
Speckled Structures (TSS) with forms of the catalytic subunit o f DNA-PK (DNA-PKcs) 
that are phosphorylated at serine residue 2056 (S2056) and threonine residue 2609 
(T2609), and that these phosphorylated forms are increased in Tax-expressing cells. The 
kinase activity o f DNA-PK is found to be increased in the presence of Tax. We also
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
70
demonstrate that DNA-PK activity mediates Tax activation of Chk2, a known target of 
DNA-PK phosphorylation (177). Further, while ionizing radiation (IR)-induced 
phosphor-DNA-PKcs and y-H2AX DNA damage foci normally resolve within 8 hours 
post-irradiation, in the presence of Tax these foci remain. Collectively, these data 
demonstrate that through direct interaction with DNA-PK, Tax interferes with the cellular 
DNA damage response.
Experimental Procedures
Plasmids
The S-tagged expression vectors STaxGFP and SGFP were constructed by 
inserting the tax-EGFP fusion or EGFP ORF, respectively, into the Smal site ofpTriEx4- 
Neo (Novagen, Madison, WI) in frame with the amino-terminal S-tag and His-tag.
Cell Culture and Transfection
293T cells were maintained at 37°C in a humidified atmosphere of 5% C02 in air, 
in Iscove’s modified Dulbecco’s medium supplemented with 10% fetal bovine serum and 
1% penicillin-streptomycin (Invitrogen, Carlsbad, CA).
Transfections were performed by standard calcium phosphate precipitation. 
Briefly, cells were plated at 1x105 cells/mL. The following day, plasmid DNA in 2M 
CaC12 and 2X HBS were added drop wise to cells in fresh medium. Cells were incubated 
at 37°C for 6 h to overnight and fresh medium was added. The cells were harvested 48 h 
post-transfection, following a single wash with IX PBS, in M-Per mammalian protein
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extraction reagent (Pierce, Rockford, IL) with protease inhibitor cocktail (Roche, Palo 
Alto, CA) and immediately frozen at -80°C.
Protein Purification
Prepared cell lysate (1.5 mL) was incubated with 75 pi bed volume of S-protein 
agarose (Novagen, Madison, WI) for 30 min at room temperature, then washed 3 times 
with 1 mL Bind/Wash Buffer (20 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% TritonX- 
100). Washed beads were eluted by resuspension in 150 pi Laemmli Sample Buffer 
(Bio-Rad, Hercules, CA) with P-Mercaptoethanol, followed by boiling for 5 min. Eluates 
were electrophoresed in a 10% SDS 1-D polyacrylamide gel and visualized by 
SilverQuest silver staining (Invitrogen, Carlsbad, CA). Bands of interest were manually 
excised from the gel for further analysis.
Immunoprecipitation
Whole cell lysate (~2 mg) in 500 pi volume was incubated with 5 pi anti-Tax 
polyclonal antibody at 4°C overnight, with constant rotation. The lysate was then 
incubated with 100 pi Protein A Sepharose beads (Zymed, San Francisco, CA) while 
rotating for 1 h at 4°C. The beads were washed 3X with 1 mL each IX SNNTE buffer 
(5% sucrose, 500 mM NaCl, 1% Nonidet P-40, 50mM Tris-HCl [pH 7.4], 5 mM EDTA). 
Proteins were eluted from beads by resuspension in 100 pi Laemmli sample buffer (Bio- 
Rad, Hercules, CA) with P-mercaptoethanol, and boiled for 5 min.
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Immunoblot Analysis
Cell extracts were derived as described above. Total protein concentrations were 
determined by Protein Assay (Bio-Rad, Hercules, CA). An equal volume of Laemmli 
sample buffer (Bio-Rad, Hercules, CA) with P-mercaptoethanol was added to the lysate, 
boiled for 5 min, and a normalized amount of total protein was loaded in each lane and 
electrophoresed through a 6% or 10% SDS-polyacrylamide gel. In some experiments, 
protein samples were prepared in 4X LDS Sample Buffer with Sample Reducing Agent, 
and electrophoresed in a NuPAGE 4-12% Bis-Tris gel using in MES-SDS Running 
Buffer (Invitrogen, Carlsbad, CA). The proteins were transferred onto Immobilon-P 
(Millipore, Billerica, MA) membrane using a Trans-blot SD semi-dry transfer cell (Bio- 
Rad, Hercules, CA) at 400 mA for 50 min or using a Trans-blot electrophoretic transfer 
cell (Bio-Rad, Hercules, CA) at 800 mA for 4 h in transfer buffer (25 mM Tris, 200 mM 
glycine, 20% methanol, 0.1% SDS). Following blocking in 5% non-fat milk in 
PBS/0.1% Tween-20, blots were incubated in primary antibody overnight, followed by 1 
h incubation in secondary horseradish-peroxidase conjugated anti-mouse or anti-rabbit 
antibody (Bio-Rad, Hercules, CA). Immunoreactivity was detected via Immunstar 
enhanced chemiluminescence protein detection (Bio-Rad, Hercules, CA).
LC-MS/MS Analysis
Protein bands were excised from 1-D polyacrylamide gels. Gel slices were cut 
into 1-2 mm cubes; washed 3X with 500 pL ultra-pure water and incubated in 100% 
acetonitrile for 45 minutes. The material was dried in a speed-vac, rehydrated in a 12.5 
ng/pL modified sequencing grade trypsin solution (Promega, Madison, WI) and
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incubated in an ice bath for 40-45 min. The excess trypsin solution was then removed 
and replaced with 40-50 pL of 50mM ammonium bicarbonate, 10% acetonitrile, pH 8.0 
and the mixture was incubated overnight at 37°C. Peptides were extracted 2X with 25 pi 
50% acetonitrile, 5% formic acid and dried in a speed-vac. Digests were resuspended in 
20 pL Buffer A (5% acetonitrile, 0.1% formic acid, 0.005% heptafluorobutyric acid) and 
3-6 pL were loaded onto a 12-cm x 0.075 mm fused silica capillary column packed with 
5 pM diameter C-18 beads (The Nest Group, Southboro, MA) using a N2 pressure vessel 
at 1100 psi. Peptides were eluted over 55 minutes, by applying a 0-80% linear gradient 
of Buffer B (95% acetonitrile, 0.1% formic acid, 0.005% heptafluorobutyric acid) at a 
flow rate of 130 pL/min with a pre-column flow splitter resulting in a final flow rate of 
~200 nl/min directly into the source. In some cases the gradient was extended to 150 
minutes to acquire more MS/MS spectra. A LCQ™ Deca XP (ThermoFinnigan, San 
Jose, CA) was run in an automated collection mode with an instrument method composed 
of a single segment and 4 data-dependent scan events with a full MS scan followed by 3 
MS/MS scans o f the highest intensity ions. Normalized collision energy was set at 30, 
activation Q was 0.250 with minimum full scan signal intensity at 5 x 105 and a minimum 
MS2 intensity at 1 x 104. Dynamic exclusion was turned on utilizing a three minute 
repeat count of 2 with the mass width set at 1.50 Da. Sequence analysis was performed 
with TurboSEQUEST™ (ThermoFinnigan, San Jose, CA) or MASCOT (Matrix 
Sciences, London, GB) using an indexed human subset database of the non-redundant 
protein database from National Center for Biotechnology Information (NCBI) web site 
(http://www.ncbi.nlm.nih.gov/). An additional database was created containing only the 
ORF sequence for the expressed Tax protein.
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RT-PCR
Total RNA was extracted from cells transfected with Hpx Tax expression vector, 
or mock transfected, by harvesting in Trizol reagent (Invitrogen, Carlsbad, CA), followed 
by chloroform extraction. The aqueous layer was transferred to a fresh tube with 
isopropanol, and the mixture was applied to an RNeasy column (Qiagen, Valencia, CA). 
RNase-free DNase was added to the wash buffer, and RNA was eluted with RNase-free 
water. Gene expression was measured using the Access RT-PCR System (Promega, 
Madison, WI) for coupled reverse transcription and PCR amplification, according to the 
manufacturer’s protocol. Briefly, 10 ng of RNA template was reverse transcribed using 
AMV Reverse Transcriptase for first strand cDNA synthesis and Tfl DNA Polymerase 
for second strand cDNA synthesis and DNA amplification. 18S rRNA was amplified as 
an internal control for equal total RNA using primers: 5’-
T G ACT CT AG AT AACCT CGGG (forward) and 5 ’ -CCC AAG AT CC AACT ACG AGC 
(reverse). A 348 bp fragment o f DNA-PKcs cDNA (3325-3672 bp) was amplified using 
primers: 5 ’ - AGGG AAG AAG AGT CT CT GGT GG (forward) and 5’-
ATTAGGGGATCTGTTGCCTGGC (reverse).
Deletion Mutagenesis
Deletion mutagenesis was performed using QuikChange XL mutagenesis kit 
(Stratagene, La Jolla, CA) to delete between 29 to 52 amino acid stretches along the 
length of the 353-amino acid Tax sequence in the context of the fusion protein, 
STaxGFP. Forward and reverse primers were designed to anneal to the 5’ and 3’ regions 
flanking the desired deletion. Methylated original STaxGFP plasmid derived from
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bacteria was used as the template, and mutagenic primers were extended with PfuTurbo 
high-fidelity DNA polymerase during an 18-cycle PCR, deleting the desired sequence 
from the newly synthesized strands. The remaining methylated template was digested by 
the Dpnl provided, and the PCR product was used to transform XL10-Gold competent 
bacteria. Bacterial colonies growing under ampicillin selection were selected for further 
processing and correct plasmids were purified using the PureLink HiPure Plasmid Filter 
Maxiprep Kit (Invitrogen, Carlsbad, CA). Introduction of the correct deletion mutation 
was confirmed by DNA sequence analysis (Davis Sequencing, Davis, CA), and 
expression was confirmed by transfection and immunoblot analysis using anti-GFP 
monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA).
Immunofluorescence
293T cells were seeded onto 22-mm diameter coverslips in 6-well plates at lxlO5 
cells/well. Transfections were performed as described above, and 48 h later cells were 
washed twice with PBS, fixed in 4% paraformaldehyde and permeabilized with 
methanol. Coverslips were incubated with primary antibody in 3% BSA/PBS overnight 
at 4°C, followed by 2 washes in PBS/0.1% Tween20 and 2 washes in PBS. Coverslips 
were then incubated in secondary antibody with the addition o f 1 pM TOPRO-3-iodide 
(Molecular Probes, Eugene, OR) for 1 h at room temp followed by 2 washes in 3% 
BSA/PBS and 2 washes in PBS. Coverslips were mounted in Vectashield containing 
DAPI (Vector Laboratories, Burlingame, CA). Fluorescent images were acquired using a 
Zeiss LSM 510 confocal microscope at 40X magnification with a 2.8X zoom using
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Argon (488 nm), HeNel (543 nm), and HeNe2 (633 nm) lasers, and imaged with LSM 
Image Browser software (Carl Zeiss, Jena, Germany).
Nuclear Extracts
Five confluent 150-mm plates of transfected 293T cells were washed twice in 
cold PBS, and harvested by scraping in 3 mL Buffer A (10 mM HEPES [pH 7.9], 1.5 
mM MgCl2, 10 mM KC1, 0.5% Nonidet P-40, 0.5 mM dithiothreitol, protease inhibitor 
cocktail [Roche, Indianapolis, IN]). Cell solutions were incubated for 10 min on ice for 
lysis. Nuclei were centrifuged at 2000 rpm for 10 min at 4°C. The supernatant was 
discarded, and 1 mL Buffer C (20 mM HEPES [pH 7.9], 25% glycerol, 420 mM NaCl, 
1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM dithiothreitol, protease inhibitor cocktail, 
[Roche]) was added to the pellet. The resuspended pellet was incubated on ice for 30 
min and mixed gently every 5 min by pipetting up and down. The sample was 
centrifuged at 14000 rpm for 30 min at 4°C. The supernatant was dialyzed against Buffer 
D (20 mM HEPES [pH 7.9], 20% glycerol, 100 mM KC1, 0.2 mM EDTA, 0.5 mM 
PMSF, 0.5 mM dithiothreitol) for 5 h to overnight at 4°C. Nuclear extracts were stored 
in aliquots at -80°C.
DNA-dependent Protein Kinase Assay
Protein kinase activation was assayed using the SignaTECT® DNA-Dependent 
Protein Kinase Assay System (Promega, Madison, WI). Following the manufacturer’s 
protocol, reactions (25 pi) contained nuclear extract, DNA-PK activation buffer, reaction 
buffer, a biotinylated p53-derived peptide containing a serine residue targeted for
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phosphorylation by DNA-PK, and 0.5 pCi [y-32P]ATP (10 mCi/ ml). In some reactions, 
extracts were pre-incubated with 10 pM DNA-PK inhibitor II (Calbiochem, San 
Diego,CA) for 1 h on ice before being added to the reaction. Samples were incubated at 
30°C for 10 min. Termination buffer containing guanidine hydrochloride was then added 
and 10 pi of each reaction mixture was spotted onto SAM2® Biotin capture membrane, 
containing biotin-binding streptavidin matrix. After washing with 2 M NaCl, membranes 
were dried and incorporated 32P-phosphorylated substrate measured by scintillation 
counting.
Chk2 Kinase Assay
The plasmid pCDNA4-Chk2 in combination with pCDNA3-Tax (provided by 
Ralph Grassmann, Germany) or control plasmid expressing non-specific protein was 
subjected to in vitro transcription/translation using the Rabbit Reticulocyte Lysate System 
(Promega, WI). Standard 50-pl reactions were performed following the manufacturer’s 
protocol. 8 pi of the in vitro translation product was mixed with 300 pi NETN buffer (20 
mM Tris-HCl [pH 8.0], 0.1 M NaCl, 1 mM EDTA, 0.5% Nonidet P-40, protease inhibitor 
cocktail [Roche]) for immunoprecipitation using 2 pg of anti-Xpress tag antibody 
(Invitrogen, Carlsbad, CA) for 3 h. Precipitates were washed twice with NETN buffer 
lacking protease inhibitors followed by a final wash with IX kinase assay buffer (20 mM 
Tris [pH 7.5], 10 mM MgCl2, 10 mM MnCL, 1 mM dithiothreitol). In some reactions, 
precipitated Chk2 immune complexes were pre-incubated with 10 pM DNA-PK inhibitor 
II (Calbiochem, San Diego,CA) for 1 h on ice before being added to the kinase reaction. 
Reactions were incubated at 30°C for 10 min in IX kinase assay buffer supplemented
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with 2 (J.M unlabeled ATP and 10 pCi of [y-32P]ATP (Pierce). The reaction mixture was 
resolved on a 10% SDS-polyacrylamide gel, dried and subjected to phosphor-imaging 
using a Typhoon scanner (GE Health Care, NJ). Relative intensity o f the bands was 
calculated by densitometry.
Results
Identification o f DNA-PK in Tax Complex
In order to identify cellular proteins that interact with Tax in vivo, we created a 
tandem affinity-tagged Tax construct that could be expressed and purified from 
mammalian cells in a complex with its cellular binding partners. The previously 
described STaxGFP vector expresses biologically active full-length Tax protein fused to 
amino-terminal His6- and S-tags to facilitate affinity purification, and carboxy-terminal 
green fluorescent protein (GFP) to facilitate monitoring of protein expression and 
localization (56). We purified S-tagged Tax protein from transiently transfected 293T 
cells along with interacting cellular proteins and further resolved these proteins by SDS- 
PAGE and visualized them by silver staining (Fig. 13.4). Individual bands were manually 
excised from the gel and proteins were identified by LC-MS/MS analysis. STaxGFP was 
identified from a band of the expected size on the gel, as indicated (Fig. 13.4). In 
addition, a high-molecular weight band was identified as the catalytic subunit o f DNA- 
dependent Protein Kinase (DNA-PKcs). This band was not present in S-tag purifications 
from control cells transfected with SGFP. To confirm the correct identification of the 
band, replicate samples were resolved by SDS-PAGE and immunoblotted with antibody 
specific to DNA-PKcs (Fig. 135). This blot clearly indicates that DNA-PKcs is present
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Fig. 13. Identification of DNA-PK in Tax complex. Cell lysates from 293T 
cells transiently transfected with SGFP or STaxGFP (indicated) were affinity purified on 
S-protein agarose beads as described under “Experimental Procedures” and subjected to 
SDS-PAGE and analysis by silver staining (A) or immunoblotting with anti-DNA-PKcs 
antibody (Neomarkers, Fremont, CA) (B). The band representing DNA-PKcs is 
indicated. Crude lysate from STaxGFP-transfected cells was loaded as a control (input) 
(B). C, co-immunoprecipitation of Tax and DNA-PKcs from 293T cells. Cell lysates 
from STax-transfected or SGFP-transfected cells as indicated (input), were 
immunoprecipitated with anti-Tax or anti-GFP polyclonal antibodies as indicated (IP 
Ab). The resulting precipitates were subjected to SDS-PAGE and immunoblot analysis 
using anti-DNA-PKcs monoclonal antibody (Neomarkers). D, co-immunoprecipitation of 
Tax and Ku70 from 293T cells. Cell lysates from Tax-transfected cells (input) were 
immunoprecipitated with anti-Tax or anti-GFP polyclonal antibodies as indicated (IP 
Ab). The resulting precipitates were subjected to SDS-PAGE and immunoblot analysis 
using anti-Ku70 monoclonal antibody (Neomarkers).
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in the S-tag purification from cells transfected with STaxGFP, but not from cells 
transfected with control SGFP (Fig. 135).
We next sought to confirm that Tax interacts with cellular DNA-PK by co- 
immunoprecipitation experiments. Tax complexes were immunoprecipitated from whole 
cell lysates with anti-Tax antibody, and an immunoblot with anti-DNA-PKcs antibody 
revealed that DNA-PKcs is present in the Tax complex (Fig. 13 C). DNA-PKcs could not 
be detected when the control anti-GFP antibody was substituted for Tax antibody, or 
when SGFP was substituted for Tax in the whole cell lysate, indicating the specificity of 
the Tax-DNA-PKcs interaction (Fig 13 C).
The DNA-PK holoenzyme consists of a catalytic subunit as well as two regulatory 
subunits, Ku70 and Ku80 (149,178). Co-immunoprecipitation experiments show that 
Ku70 is isolated from Tax-expressing cells with anti-Tax antibody but not with control 
anti-GFP antibody, indicating the Ku70 regulatory subunit of DNA-PK is also in the Tax 
complex (Fig. 13D).
Induction o f Phosphorylated DNA-PK by Tax
We next sought to determine whether Tax affects the expression of DNA-PK 
through its function as a trans-activator. Gene expression of DNA-PKcs is not changed 
in the presence of Tax, as measured by semi-quantitative RT-PCR (Fig. 14,4). In 
addition, immunoblot experiments indicate that overall DNA-PKcs protein expression is 
also unaffected by Tax (Fig. 145). However, this experiment revealed a strong increase 
in phosphorylated forms o f DNA-PKcs in the presence of Tax (Fig. 145). 
Phosphorylation of DNA-PKcs at S2056 and T2609 has been shown to occur after DNA
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FIG. 14. Induction of phosphorylated DNA-PKcs by Tax. A, semi- 
quantitative RT-PCR using primers specific for DNA-PKcs (indicated) or control primers 
for 18S rRNA (indicated) for normalization to amplify cDNA from untransfected {mock) 
or Tax-transfected (Tax) 293T cells. DNA-PKcs-specific primers were included in a 
negative control reaction with no template DNA (No template). B, nuclear extracts from 
untransfected (mock) or Tax-transfected (Tax) 293T cells were subjected to SDS-PAGE 
and immunoblot analysis with the indicated antibodies. Alpha-tubulin (a-Tubulin) was 
used as control to demonstrate equal protein loading. C, 293T cells were transiently 
transfected with STaxGFP (green), fixed and permeabilized, and immunostained with 
anti-DNA-PKcs (phospho T2609) mouse monoclonal antibody (DNA-PK pT2609) or 
anti-DNA-PKcs (phospho S2056) rabbit polyclonal antibody (DNA-PK S2056), followed 
by the corresponding Alexa-594-conjugated anti-mouse or anti-rabbit secondary antibody 
(Molecular Probes) (red), along with DAPI and TOPRO-3-iodide to stain the nuclei 
(blue). The merged image shows the colocalized area represented in yellow (merge).
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damage induced by ionizing radiation (IR)(179,180). We found that the expression of 
Tax alone, without external DNA damage agents, is sufficient to induce phosphorylation 
of DNA-PKcs. Furthermore, these phosphorylated forms of DNA-PKcs co-localize with 
Tax in nuclear Tax Speckled Structures (TSS) (Fig. 14Q. Immunofluorescence 
experiments demonstrate that phosphorylated DNA-PKcs is present in characteristic 
nuclear foci only in the Tax-expressing cells (Fig. 14Q. Collectively, the data from the 
immunoblot and immunofluorescence experiments indicate that Tax induces the 
phosphorylated form of DNA-PKcs, and specifically co-localizes with it at discrete 
nuclear sites.
Redistribution o f DNA-PK by Tax Deletion Mutants
In order to determine which domains in Tax are required for interaction with 
DNA-PKcs, we designed a series o f deletion mutants along the length of Tax (Fig. 15, A 
and B). Using immunofluorescence, we examined the localization of the Tax mutants 
along with DNA-PKcs (phosphor T2609) (Fig. 16) and DNA-PKcs (phosphor S2056) 
(data not shown). Both phosphorylated forms of DNA-PKcs showed similar expression 
patterns. All o f the Tax mutants showed cytoplasmic localization, except for the mutants 
deleted from amino acids 52-99 or 322-353 (Fig. 16). Interestingly, phosphor-DNA- 
PKcs relocates to the cytoplasm in the presence of the cytoplasmic Tax deletion mutants 
1-29, 29-52, and 99-150 (Fig. 16). These data indicate that the Tax regions from amino 
acids 1-52 and 99-150 are dispensable for interaction with DNA-PKcs. The interaction 
between the cytoplasmic Tax mutants and DNA-PKcs is strong enough to redistribute 
DNA-PKcs from the nucleus to the cytoplasm.
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Fig. 15. Efficient expression of Tax deletion mutants. A, a depiction of 
deletion mutants of STaxGFP. The deleted amino acids are indicated. B, immunoblot 
using anti-GFP antibody of whole cell lysates from 293T cells transfected with either 
wild type Tax (STaxGFP) or Tax deletion mutant (indicated).
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Fig. 16. Redistribution of DNA-PK by Tax deletion mutants. 293T cells were 
transfected with wild type Tax (STaxGFP) or Tax deletion mutant (indicated) {green), 
fixed and permeabilized and immunostained with anti-DNA-PKcs (phospho T2609) 
mouse monoclonal antibody (DNA-PKpT2609) followed by Alexa-594-conjugated anti­
mouse secondary antibody {red), along with DAPI and TOPRO-3-iodide to stain the 
nuclei {blue). The merged image shows the colocalized area represented in yellow 
{merge).
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
85
DAPI STGd99-150 DAPI STGdl 50-202
DNA-PK pT2609 
DAPI
DNA-PK pT2609 
DAPI
m erge
STGd202-254
DNA-PK pT2609merge m erge
DAPI STGd289-322 DAPI STGd322-353
DNA-PK PT2609 merge DNA-PK pT2609 merge
F ig . 16. C ontinued.
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
86
Tax Activation o f DNA-PK Kinase Activity
The DNA-PK enzyme functions as a kinase, and therefore, we investigated the 
effect of Tax expression on DNA-PK kinase activity. Using an in vitro kinase assay, we 
determined that in the presence of Tax, DNA-PK has increased kinase activity (Fig. \1A). 
This assay measures phosphorylation of a p53-peptide substrate that is a known target of 
DNA-PK, and the specificity of the assay for DNA-PK is demonstrated by the loss of 
kinase activity in the presence of DNA-PK inhibitor (Fig. 17^ 4). One of the known 
phosphorylation targets of DNA-PK is the DNA damage response protein Chk2, and this 
phosphorylation at threonine residue 68 activates Chk2, and usually occurs in response to 
DNA damage (177). Our lab and others have shown that Tax interacts with Chk2 
(112,143) and increases its kinase activity (S. Gupta, unpublished data). We demonstrate 
here that activation o f Chk2 by Tax is dependent on DNA-PK, as shown by a decrease in 
Tax-induced Chk2 activation in the presence of DNA-PK inhibitor (Fig. 172?). These 
data suggest that the increased activity o f DNA-PK in Tax-expressing cells contributes to 
the observed increased Chk2 activity in these cells.
Retention o f IR-induced Phosphor-DNA-PK and y-H2AX Foci by Tax
The formation of y-H2AX nuclear foci at the site of DNA strand breaks is an 
early cellular response to a DNA damage event (181). Phosphorylation of DNA-PKcs at 
S2056 and T2609 also occurs following DNA damage, and phosphor-DNA-PKcs co- 
localizes with y-H2AX in nuclear foci (179,180). Since we observed that Tax co- 
localizes with phosphor-DNA-PKcs in the absence of an external source of DNA
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F ig . 17. Tax activation of DNA-PK kinase activity. A, dilutions (indicated) of 
nuclear extracts from 293T cells transfected with Tax (+Tax, closed triangle) or 
untransfected control cells (-Tax, open square) were prepared. DNA-PK enzyme activity 
was quantitated using the SignaTECT® DNA-PK Assay System (Promega), either in the 
presence (+ DNAPK inhibitor, closed circle and open diamond) or absence of DNA-PK 
inhibitor (Calbiochem) (closed triangle and open square). B, DNA-PK activity mediates 
Tax activation of Chk2 kinase. Kinase assays were performed using in vitro 
transcribed/translated Chk2 and Tax (Chk2+Tax) or Chk2 alone (Chk2), in the presence 
or absence of DNA-PK inhibitor (indicated). The reaction mixtures were subjected to 
SDS-PAGE and phosphorimaging analysis. Bands were quantitated by densitometry.
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damage, we asked what would happen to IR-induced phosphor-DNA-PKcs and y-H2AX 
foci in the presence of Tax. y-H2AX foci appear within minutes after IR, and phosphor- 
DNA-PKcs foci are easily observed by 30 min post-IR (179,181). Both foci normally 
resolve by 6 to 8 h post-IR (179,182). Indeed, we observed a typical time course of DNA 
damage foci-induction in the absence of Tax, with resolution o f phosphor-DNA-PKcs 
and y-H2AX foci by 8 h post-IR. However, in Tax-expressing cells at 8 h post-IR, we 
observe the continued presence of phosphor-DNA-PKcs and y-H2AX foci (Fig. 18). 
While a normal cell is able to resolve the DNA damage-induced foci in the appropriate 
time, Tax-expressing cells do not resolve the foci. These foci are present in conjunction 
with Tax even in the absence of applied DNA damage (Fig. 18, No IR).
Discussion
Oncogenesis can occur through an accumulation of mutations in the cellular 
genome which can be mechanistically attributed to chromosomal instability or loss of 
DNA repair function. Chromosomal instability results in polyploidy and aneuploidy, 
while loss of DNA repair function results in structurally damaged chromosomes bearing 
point mutations, deletions, substitutions, and translocations. Many of these features are 
demonstrated in HTLV-1-mediated transformation. Aneuploidy is a striking feature of 
ATL cells, which have multilobulated nuclei, commonly referred to as “flower” cells 
(25). Meanwhile, Tax expression alone causes multi-nucleated (polyploid) cells (79,80). 
HTLV-1-transformed lymphocytes derived from patients contain a variety of 
chromosomal abnormalities, including translocations, rearrangements, duplications and
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Fig. 18. Retention of IR-induced phosphor-DNA-PK and y-H2AX foci by 
Tax. 293T cells were transfected with Tax (STaxGFP), and 48 h later treated with 5 Gy 
ionizing radiation. Cells were fixed and permeabilized at the indicated times post­
irradiation and co-immunostained with anti-DNA-PKcs (phospho T2609) mouse 
monoclonal antibody (DNA-PK pT2609) followed by Alexa-63 3-conjugated anti-mouse 
secondary antibody, and anti-y-H2AX rabbit polyclonal antibody followed by Alexa-594- 
conjugated anti-rabbit secondary antibody (y-H2AX). The merged image shows the 
colocalized area (merge).
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deletions (81). Chromosomal damage is a characteristic o f Tax-expressing cells, as 
observed by the induction of midronuclei (MN), which represent fragmented 
chromosomes indicative o f DNA damage, or defects in DNA repair or in chromosomal 
segregation (82). Understanding the interaction of Tax with the cellular DNA damage 
response pathway is important for elucidating the mechanism of induction of genomic 
instability.
DNA double strand breaks (DSB) are possibly the most dangerous type of DNA 
damage. While DSBs can be caused by exposure to ionizing radiation, they can also be 
caused endogenously by exposure to reactive oxygen species, by-products of cellular 
metabolism. Impairment o f the DSB repair pathway can lead to gross chromosomal 
abnormalities caused by premature entry of cells into mitosis before DSBs are repaired, 
by rejoining of DSBs on different chromosomes, by the fusion of chromosome ends with 
eroded telomeres, or by defective repair (183). DNA repair genes are thus essential for 
maintaining genomic integrity (184).
The predominant DSB repair pathway in mammalian cells is non-homologous end 
joining (NHEJ), in which broken DNA ends are rejoined. The DNA-dependent Protein 
Kinase (DNA-PK) is the key enzyme in the NHEJ pathway o f DSB repair (146-149). 
Along with playing a key role in DNA repair via NHEJ, DNA-PK is also involved in 
other important responses to DSBs, including cell cycle arrest and apoptosis (148). A 
further role for DNA-PK has been shown in maintaining telomeres to prevent them from 
being recognized as DSBs. In fact, in the absence of DNA-PK, cells exhibit telomeric 
fusions and increased chromosomal instability (150). DNA-PK is thus critically involved
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in many important cellular responses to DNA damage and maintenance of genomic 
integrity.
The DNA-PK enzyme is a nuclear serine/threonine kinase consisting of an 
approximately 470 kDa catalytic subunit (DNA-PKcs) and a regulatory subunit 
composed of the Ku70/Ku80 heterodimer. Based on structural homology, DNA-PKcs 
belongs to a family o f protein kinases known as phosphatidylinositol 3-kinase-like 
protein kinases (PI3KK), which includes DNA damage response proteins, ATM and 
ATR. The kinase activity o f DNA-PKcs is stimulated by physical association with 
double-strand DNA. The process of NHEJ DSB repair involves recognition and binding 
of the Ku heterodimer to damaged DNA ends, recruitment and activation of DNA-PKcs 
and DNA end-processing factors including Artemis, and recruitment of DNA polymerase 
and XRCC4/ligase IV complex to re-ligate DNA (147). A wide range of proteins have 
been identified in vitro as substrates of DNA-PK kinase activity. These include many 
proteins in the DNA damage repair complex such as: Ku70 and Ku80, histone H2AX, 
replication protein A (RPA), XRCC4, and Chk2 (147,177). DNA-PKcs also 
phosphorylates tumor suppressor protein p53 in vitro on serine residues 15 and 37, sites 
important for regulation of its activity (140). In addition, autophosphorylation of DNA- 
PKcs at S2056 and T2609 is important for repair activity in vivo (179,180,182). Thus, 
through multiple activities, DNA-PK is an important regulator of the cellular response to 
DNA damage.
While the mammalian cell relies on the NHEJ pathway for quick repair o f DSBs, 
the processing and rejoining of DNA ends is error-prone, typically involving deletions of 
1-10 bases from the ends of broken DNA to regions of microhomology (185).
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Significantly, an increase in DNA-PKcs expression and kinase activity is associated with 
a number of cancers. Gene expression of DNA-PKcs was upregulated in a human 
hepatoma cell line as compared to normal liver (186). A study comparing tumor tissues 
and adjacent normal tissues in colorectal cancers found a significant increase in both 
DNA-PKcs mRNA and protein expression in tumor tissues, as well as increased DNA- 
PK kinase activity (187). Interestingly, increased DNA-PKcs protein expression and 
kinase activity were also seen in metastatic and multi-drug resistant cancer cell lines 
compared to their parental cells (188). The precise regulation of DNA-PK thus seems to 
be essential for its role as a suppressor o f genomic instability.
Autophosphorylation is a major mechanism for regulation of DNA-PKcs function 
in the repair process. When autophosphorylation is blocked by mutation of specific 
residues in DNA-PKcs, DSB rejoining is impaired and radiation sensitivity is increased 
(179,180,182,189). Interestingly, appropriate dephosphorylation appears to be an equally 
important step in the repair process. In a proposed model of NHEJ, dephosphorylation of 
DNA-PKcs promotes disassembly o f the protein-DNA complex at the end of the repair 
process and presumably initiates recycling of the component proteins for future repair 
events (146,190,191). Dephosphorylation of DNA-PKcs is attributed to the activity of 
protein phosphatase 5 (PP5) (192). Hyperphosphorylation of DNA-PKcs at S2056 and 
T2609 by a PP5 dominant negative mutant actually resulted in increased radiosensitivity, 
indicating that prolonged phosphorylation at these sites is detrimental to DNA-PK repair 
function (192).
In the current study, we found that the HTLV-1 oncoprotein Tax interacts with 
DNA-PKcs and Ku70 in a complex. Furthermore, Tax induced hyperphosphorylation of
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DNA-PKcs at S2056 and T2609, and co-localized with these phosphorylated forms in 
nuclear foci. Experiments using Tax deletion mutants that are nuclear excluded 
demonstrated redistribution of phosphor-DNA-PKcs to the sites where the Tax mutants 
are localized. This provides evidence of a strong interaction of Tax and DNA-PKcs, and 
the deletion analysis suggests that a large portion of the Tax sequence may be required 
for the interaction, with the exception of amino acids 1-52 and 99-150 which are 
dispensable.
In addition to the physical interaction o f Tax with DNA-PKcs, we found 
increased DNA-PK kinase activity in Tax-expressing cells. Elevated DNA-PK kinase 
activity is correlated with a number of human cancers and with both metastatic and multi­
drug resistant phenotypes (185-188). We postulate that the increased DNA-PK activity 
observed in Tax-expressing cells contributes to the genomic instability observed in these 
cells. Inappropriate activation of the NHEJ pathway could result in aberrant processing 
and joining of noncontiguous broken DNA ends, leading to translocations and deletions. 
Such repair infidelity was observed in myeloid leukemia cells which are characterized by 
genomic instability, and were shown to have increased DNA-PK activity and DSB 
misrepair (193). Further studies will be required to determine whether Tax-expressing 
cells have a higher rate of DSB misrepair.
DNA-PK has multiple phosphorylation targets demonstrated in vitro which 
require appropriate phosphorylation for proper function. Chk2 is a cell cycle checkpoint 
protein which is activated during the DNA damage response by phosphorylation, and is 
an in vitro substrate for DNA-PK (177). Our laboratory has shown that phosphorylated 
Chk2 is elevated in Tax-expressing cells and Chk2 activation leads to delayed
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progression through the G2/M checkpoint (112). Using DNA-PK inhibitors, we 
demonstrated that increased Chk2 phosphorylation in Tax-expressing cells is dependent 
upon DNA-PK kinase activity. Increased DNA-PK activity could thus lead to increased 
phosphor-Chk2 whose activity results in inappropriate checkpoint activation. Persistant 
activation of cell cycle checkpoints is an early step in tumorigenesis that leads to genomic 
instability (183,184).
Another in vitro target of DNA-PK is the p53 tumor suppressor, a key protein in 
the response to DNA damage and cell stress, which has been shown to be phosphorylated 
by DNA-PK on serine residues 15 and 37 (140). While mutation of p53 is common in 
human cancers, it is not mutated in most HTLV-1-transformed cells (121). However, 
there is evidence that Tax can inactivate p53 function through a proposed mechanism 
involving hyperphosphorylation of p53 at serine 15 and 392, which interferes with the 
function of p53 as a transcriptional activator (194,195). Although it has been suggested 
that the phosphorylation mechanism through which Tax inactivates p53 is DNA-PK- 
dependent (194,195), another study found that Tax-mediated p53 inactivation still occurs 
in DNA-PKcs-deficient cells (196). However, due to overlapping roles o f DNA-PK with 
other DNA damage response proteins, ATM and ATR (197,198), we cannot rule out the 
possibility that other proteins in these cells compensated for the lack of DNA-PK.
Another protein that was reported to be a phosphorylated substrate of DNA-PK in 
vitro is the oncoprotein, c-myc (199). Deregulation of c-myc expression is observed in 
many human tumors, and there is evidence that HTLV-1 Tax can also deregulate c-myc 
function (200,201). A DNA-PKcs-knockdown study suggested that DNA-PK activity 
may regulate expression of c-myc protein (202). Considering our current data indicating
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an interaction between Tax and DNA-PK and the effect on DNA-PK activity, it is 
possible that the mechanism of Tax-mediated c-myc deregulation is DNA-PK-dependent. 
Further studies are required to investigate this hypothesis.
Increased DNA-PK activity may also have detrimental consequences for the 
maintenance of chromosomal stability in cells expressing Tax, due to its role in telomere 
capping. Telomeres protect chromosome ends from degradation and prevent 
chromosomal end fusion (203). DNA-PKcs is critical for telomere capping, and DNA- 
PKcs-deficiency promotes increased chromosomal instability and telomeric fusions 
(203,204). A study examining the role of DNA-PKcs in the context of telomerase 
inactivation proposed a model in which NHEJ-mediated telomere fusions are an outcome 
of critically short telomeres induced by telomerase deficiency (205). According to this 
model, an increase in DNA-PK activity would certainly have a detrimental effect in Tax- 
expressing cells, in which telomerase activity is decreased by Tax-mediated repression of 
human telomerase reverse transcriptase (hTert) (129). Tax-expressing cells display 
frequent unstabilized DNA breaks detected as unprotected free 3'-OH DNA ends 
(128,130). Telomerase inactivation by Tax would promote unstabilized telomeres which 
could result in end-to-end chromosomal fusions in the context o f increased DNA-PK 
activity, resulting in the cytogenetic abnormalities observed in HTLV-1-infected cells 
(206).
In this study we provide evidence that Tax alters the function of DNA-PK in 
response to DNA damage. Tax-expressing cells subjected to ionizing radiation (IR) 
demonstrated a defect in the DNA damage response by their inability to appropriately 
resolve damage-induced phosphor-DNA-PKcs and y-H2AX foci. Treatment o f cells with
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IR induces DNA-PKcs autophosphorylation and y-H2AX foci formation, which normally 
begin to resolve by 8 h post-IR (179-182). Significantly, in Tax-expressing cells we 
observed prolonged phosphorylation of both DNA-PKcs and H2AX at 8 h post-IR and, 
indeed, we saw phosphorylation o f these damage response proteins even in the absence of 
IR. The hyperphosphorylation observed in cells expressing Tax indicates a defect in the 
DNA-PK repair pathway. Further investigation is required to determine whether Tax 
affects the kinase disassembly step in a proposed model of the repair process (146), 
interfering with recycling of repair factors for additional rounds of repair.
An interesting question is why a retrovirus would interact with DNA repair 
proteins. The NHEJ pathway has been implicated in the early steps of retroviral 
infection. Specifically, DNA-PK may play a role in retroviral DNA integration, as 
evidenced by inefficient retroviral integration in DNA-PKcs-deficient mouse cells (207). 
Furthermore, increased apoptotic cell death is observed in these retroviral-infected cells, 
suggesting DNA-PK protects cells from toxicity caused by infection (207,208). A 
proposed model suggests that unintegrated retroviral cDNA promotes apoptosis, and 
activation o f the NHEJ pathway protects the cell by recognizing the cDNA double-strand 
ends and causing circularization (209). It would be beneficial to a retrovirus to activate 
the NHEJ pathway to evade apoptosis, and is a logical action for the HTLV-1 protein 
Tax. Unlike HTLV-1, apoptosis is a key feature of the pathogenesis o f a different 
retrovirus, Human Immunodeficiency Virus (HIV), in which apoptosis contributes to T- 
cell destruction (210). A recent study found decreased DNA-PKcs mRNA and protein 
expression in cells expressing the HIV protein, Tat, along with reduced DSB repair 
capacity (211). HIV infection combined with decreased NHEJ could contribute to the
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increased apoptosis o f infected cells (209). On the other hand, activation of the NHEJ 
pathway by HTLV-1 Tax may contribute to the endurance of HTLV-infected cells.
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SECTION 6
FUNCTIONAL ROLE OF TAX-DNA-PK INTERACTION
Introduction
Human T-cell Leukemia Virus Type 1 (HTLV-1), a transforming retrovirus, is the 
etiological agent of Adult T-cell Leukemia (ATL) and HTLV-1 Associated 
Myelopathy/Tropical Spastic Paraparesis (HAM/TSP), as well as other subneoplastic 
conditions (31). Expression of the 40-kDa viral transactivating protein, Tax, encoded by 
HTLV-1, is sufficient to cause cellular transformation (115). Although the specific 
mechanism is not fully known, it is evident that Tax induces genomic instability through 
direct interaction with various cellular proteins involved in cell cycle control and DNA 
damage repair response (112,114,115,128,130,145). Recent evidence in our laboratory 
indicates that Tax interacts with a key enzyme in the cellular response to DNA damage, 
the DNA-dependent Protein Kinase (DNA-PK) and affects its activity (S. Durkin, 
unpublished data). Considering that the fidelity o f the DNA repair pathway is critical for 
maintaining the integrity of the genome, the interaction of Tax with DNA-PK may have 
negative consequences for the cell.
DNA double strand breaks (DSBs) are the most severe form of DNA damage, and 
if  misrepaired, can lead to chromosomal abnormalities and genomic instability (212). 
The predominant DSB repair pathway in the mammalian cell is non-homologous end 
joining (NHEJ), in which broken DNA ends are rejoined. DNA-PK, a nuclear 
serine/threonine kinase, is the key enzyme in the NHEJ pathway of DSB repair (146- 
149). The process of NHEJ is rapid and error-prone due to processing and rejoining of
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
100
DNA ends using little or no homology to mend the breaks (185). The low fidelity of 
repair using this pathway can lead to mutations and chromosomal aberrations and, 
eventually, malignant transformation (213,214). Indeed, increased NHEJ repair activity 
is itself associated with various human tumors, as measured by increased DNA-PK 
protein expression and activity (186-188). In this study, we investigated the effect of Tax 
on NHEJ activity using an in vivo plasmid-based end-joining assay to measure overall 
and precise end-joining efficiency.
Along with playing a key role in DNA repair via NHEJ, DNA-PK is also involved 
in other important responses to DSBs, including cell cycle arrest and apoptosis (148). 
Interestingly, cell cycle arrest is a feature of Tax-expressing cells, in which there is 
delayed progression through the G2/M checkpoint (80,112,122). The mechanism of 
G2/M accumulation involves direct binding of Tax to the cell cycle checkpoint and DNA 
damage response protein, Chk2, which is phosphorylated and activated in Tax-expressing 
cells (112). Suppression of Chk2 using siRNA treatment abrogates the G2/M arrest 
induced by Tax (112). This effect may also be dependent on DNA-PK. Chk2 is an in 
vitro substrate for phosphorylation by DNA-PK (177), and our laboratory has shown that 
inhibition of DNA-PK abrogates Tax-induced Chk2 phosphorylation (S. Durkin and S. 
Gupta, unpublished data). In this study, we investigated the hypothesis that Tax 
interaction with DNA-PK promotes Chk2 phosphorylation and delays progression 
through the G2/M checkpoint. Using siRNA to knockdown expression o f the catalytic 
subunit o f DNA-PK (DNA-PKcs), we measured the effect on cell cycle in Tax- 
expressing cells.
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This study is designed to determine the functional significance of the interaction 
of Tax with DNA-PKcs. The results presented here do not suggest a role for Tax in 
affecting the precision o f NHEJ repair, nor do they suggest that DNA-PKcs is required 
for Tax-induced G2/M accumulation. However, as will be discussed, due to inherent 
limitations, these assays may not reflect the true situation in vivo.
Experimental Procedures
Plasmids
The STaxGFP expression vector was constructed by inserting the tax-EGFP 
fusion ORF into the Smal site ofpTriEx4-Neo (Novagen, Madison, WI) in frame with the 
amino terminal S- and His-tag.
Cell Culture and Transfection
293T cells were maintained at 37°C in a humidified atmosphere of 5% CO2 in air, 
in Iscove’s modified Dulbecco’s medium supplemented with 10% fetal bovine serum 
(Cambrex, East Rutherford, NJ) and 1% penicillin-streptomycin (Invitrogen, Carlsbad, 
CA).
Transfections o f 293T cells were performed by standard calcium phosphate 
precipitation. Cells were plated at 1x10s cells/mL. The following day, plasmid DNA in 
2M CaCI2 and 2X HBS were added dropwise to cells in fresh medium. Cells were 
incubated at 37°C for 5 h to overnight and fresh medium was added. The cells were 
harvested 48 h post-transfection, following a single wash with IX PBS, in 500 pi M-Per
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mammalian protein extraction reagent (Pierce, Rockford, IL) with protease inhibitor 
cocktail (Roche, Palo Alto, CA) and immediately frozen at -80°C.
Immunoblot Analysis
Cell extracts were derived as described above. Total protein concentrations were 
determined by Protein Assay (Bio-Rad, Hercules, CA). An equal volume of Laemmli 
sample buffer (Bio-Rad, Hercules, CA) with P-mercaptoethanol was added to the lysate, 
boiled for 5 min, and a normalized amount of total protein was loaded in each lane and 
electrophoresed through a 10% SDS-polyacrylamide gel. The proteins were transferred 
onto an Immobilon-P (Millipore, Billerica, MA) membrane using a Trans-blot SD semi- 
dry transfer cell (Bio-Rad, Hercules, CA) at 400 mA for 50 min in transfer buffer (25 
mM Tris, 200 mM glycine, 20% methanol, 0.1% SDS). Following blocking in 5% non­
fat milk in PBS/0.1% Tween-20, blots were incubated in primary antibody overnight, 
followed by 1 h incubation in secondary horseradish-peroxidase conjugated anti-mouse 
or anti-rabbit antibody (Bio-Rad, Hercules, CA). Immunoreactivity was detected via 
Immunstar enhanced chemiluminescence protein detection (Bio-Rad, Hercules, CA).
In Vivo End-joining Assay
This assay was modified from Zhong, et al. (215). pGL2-Control plasmid 
(Promega, Madison, WI) expressing the luciferase gene under control of the SV40 
promoter was completely linearized using either Hindlll or £coRI, as confirmed by 
agarose gel electrophoresis. The linearized DNA was purified using the Qiaquick PCR 
Purification kit (Qiagen, Valencia, CA). 2x105 293T cells were transfected with 5 pg
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STaxGFP or mock transfected using siPORT Amine transfection reagent (Ambion, 
Austin, TX) and incubated for 24 h. Cells were subsequently transfected with 10 jag 
either uncut, Hindlll- or EcoRI- linearized pGL2 DNA using the standard calcium- 
phosphate method. The transfectants were harvested 48 h post-transfection in Reporter 
Lysis Buffer (Promega, Madison, WI) and frozen at -80°C for luciferase assays. 
Luciferase assay substrate was used according to the manufacturer’s protocol (Promega), 
and activity was measured in a TD-20/20 luminometer (Turner Designs, Sunnyvale, CA). 
Luciferase activity was normalized for total cell protein determined from whole cell 
extracts by Protein Assay (Bio-Rad, Hercules, CA), according to manufacturer’s 
direction.
Flow Cytometry
To analyze the cell cycle profile, cells were washed once with PBS and 
centrifuged at 1000 rpm for 10 min at 4°C. The cells were fixed with the addition of 1 
mL ice-cold 70 % ethanol and incubated at 4°C overnight. The ethanol was removed by 
centrifugation and the cell pellet was washed with 2 mL PBS. Cells were resuspended in 
1 mL propidium iodide solution (50 |ig/mL propidium iodide and 100 units/mL RNase A 
in PBS) and incubated for 30 min at room temperature with gentle rotation. The cells 
were washed in PBS and resuspended in 0.5 mL PBS. DNA flow analysis was conducted 
on a FACScan (BD Biosciences, San Jose, CA) with ModFit LT software (Verity 
Software House, Topsham, ME).
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siRNA Delivery
DNA-PKcs Silencer Validated siRNA (PRKDC) or Silencer Negative Control #1 
siRNA (Ambion, Austin, TX) was delivered to 293T cells in a 6-well plate at 2x105 
cells/well using 10 pl/well siPORT Amine (Ambion), according to the manufacturer’s 
protocol. In some experiments, 4 pg STaxGFP DNA was co-transfected by incubation 
with the siRNA and siPORT Amine. 48 h later, cells were harvested for further analysis.
Results
Effect o f Tax on End-joining Repair
In order to determine the effect of Tax on the NHEJ pathway of repair, we 
developed an in vivo assay to measure end-joining in Tax-expressing cells compared to 
normal controls. This assay, modified from Zhong et al., measures both overall and 
precise end-joining repair of a linearized luciferase reporter plasmid, pGL2, transiently 
transfected into cells in the presence or absence of Tax expression (215). The luciferase 
gene is only expressed after the plasmid is end-joined to re-create the circular form. 
Relative end-joining efficiency is calculated by comparing luciferase activity of cells 
transfected with endonuclease-digested reporter plasmid with cells containing uncut 
plasmid. End-joining o f the reporter plasmid linearized with Hindlll restriction 
endonuclease, which cleaves at the linker region between the promoter and luciferase 
coding sequence, is considered overall end-joining activity because any end-joining 
activity in this region, even that resulting in small deletions or insertions, would not affect 
luciferase expression. Cleavage of the plasmid at the unique £coRI site located within 
the luciferase coding region, however, can only produce luciferase activity if  end-joined
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precisely to restore the original sequence; hence this reflects precise end-joining activity. 
This assay, therefore, allowed us to measure both the efficiency and precision of end- 
joining repair capacity in Tax-expressing cells.
Efficient expression of Tax protein in cells prior to assaying for end-joining 
activity was achieved by transient transfection of tax 24 h prior to introduction of the 
linearized reporter plasmid (Fig. 19,4). It should be noted that the majority o f cells show 
strong Tax expression, as visualized by fluorescent microscopy of the Tax-green 
fluorescent protein (GFP) fusion protein (Fig. 19,4). No significant difference in either 
overall or precise end-joining efficiency was observed in Tax-expressing cells compared 
to controls (Fig. 195).
Efficient Knockdown o f DNA-PKcs In Vivo
We next sought to determine whether DNA-PKcs plays a functional role in the 
Tax-induced delay in G2/M progression. Our strategy relied on suppressing DNA-PKcs 
expression in Tax-expressing cells and analyzing the effect on cell cycle progression. If 
DNA-PKcs is required for the Tax-induced cell cycle delay, then knocking down DNA- 
PKcs should remove the delay. Using DNA-PKcs Silencer Validated siRNA (PRKDC) 
(Ambion), we achieved efficient knockdown of DNA-PKcs protein expression, as 
measured by immunoblotting (Fig. 20,4). The knockdown effect was not seen with 
delivery of control siRNA directed at a non-specific gene (Neg. Ctrl) (Fig. 20A). We 
then delivered both DNA-PKcs siRNA (PRKDC) and DNA encoding Tax protein 
(STaxGFP) via transient transfection to achieve knockdown of DNA-PKcs in Tax- 
expressing cells. DNA-PKcs expression in cells co-transfected with DNA-PKcs siRNA
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Fig. 19. Effect of Tax on end-joining repair. 293T cells were transiently 
transfected with STaxGFP (+Tax) or mock-transfected (-Tax) and incubated for 24h to 
allow expression of STaxGFP. The right panel (A) represents cells expressing STaxGFP. 
The left panel (A) shows the light field image of the same field o f view. Cells were 
subsequently transfected with uncut, HindUI- or £coRI-linearized pGL2 luciferase 
reporter plasmid. 48 h later, the transfectants were harvested and analyzed for luciferase 
activity. The relative end-joining efficiency was calculated by comparing luciferase 
activity in cells transfected with Hindlll- or £coRI-linearized DNA (indicated) with that 
of the uncut plasmid (B).
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FIG. 20. Efficient suppression of DNA-PKcs by siRNA. A, 293T cells were 
transfected with the indicated concentrations of DNA-PKcs Silencer Validated siRNA 
(PRKDC) (Ambion) or Silencer Negative Control #1 siRNA (Neg. Ctrl) using siPORT 
Amine delivery agent (Ambion). Mock samples were treated without siRNA or siPORT 
Amine, No siRNA samples were treated with siPORT Amine alone. 48 h later, cells were 
harvested and subjected to SDS-PAGE and immunoblot analysis with using anti-DNA- 
PKcs antibody (Neomarkers), a-tubulin antibody was used as a control to show equal 
protein loading. B, cells were transfected with siRNA in the presence or absence of 
STaxGFP DNA (indicated). Immunoblot analysis using anti-GFP antibody shows 
expression of STaxGFP.
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(PRKDC) and STaxGFP was lower than in cells with Negative Control siRNA (Neg. 
Ctrl) and STaxGFP (Fig. 205). However, DNA-PKcs knockdown was not as efficient 
with co-delivery o f STaxGFP when compared to siRNA delivery alone (Fig. 205).
Cell Cycle Analysis o f Tax-expressing Cells with Reduced DNA-PKcs Expression
Using flow cytometry to measure fluorescence as well as the cell cycle profile of 
transfected cells, we were able to analyze the cell cycle of only the population of cells 
expressing Tax-GFP fusion protein by selecting only green fluorescent cells for analysis. 
However, we could not select only those cells which had received siRNA, since this 
population had no fluorescent marker. As expected, Tax-expressing cells show an almost 
two-fold increase in the percent of cells in G2/M compared to control cells (Fig. 21, left 
panels). The delivery of DNA-PKcs siRNA {PRKDC) compared to Negative Control 
siRNA {Neg. Ctrl) had no significant effect on the cell cycle profile (Fig. 21, upper 
panels). Surprisingly, knockdown of DNA-PKcs in Tax-expressing cells had no 
significant effect on G2/M arrest, as DNA-PKcs siRNA {PRKDC) delivery to these cells 
resulted in the same increase in G2/M as cells with Negative Control siRNA {Neg. Ctrl) 
and Tax (Fig. 21, lower panels). Whether this is simply due to inefficient knockdown of 
DNA-PKcs in many of the analyzed cells is not clear.
Discussion
The aim of this study was to identify a functional role for the interaction of Tax 
with DNA-PKcs in the DNA damage response pathway, with a specific investigation of 
the effect on DSB repair and G2/M arrest. We examined the effect of Tax on NHEJ
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F i g . 21. Cell cycle analysis of Tax-expressing cells with reduced DNA-PKcs.
The histograms represent the distribution of cells through the cell cycle measured by flow 
cytometry and analyzed by ModFit. Cells were transfected with Silencer Validated 
DNA-PKcs siRNA (PRKDC siRNA) (Ambion) or Silencer Negative Control #1 siRNA 
(Neg. Ctrl siRNA) (Ambion) in the presence of absence of STaxGFP DNA (indicated). 
The percentage of cells in G2/M is shown.
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repair using an in vivo plasmid-based end-joining assay. The findings presented here do 
not show a significant effect of Tax on end-joining. We also found no significant 
requirement for DNA-PKcs in Tax-induced G2/M arrest, using siRNA suppression of 
DNA-PKcs.
Previous work in our laboratory and others has shown evidence of genomic 
instability in Tax-expressing cells, which may be a result of the impact of Tax on both 
cell cycle and the DNA damage response (115,145). In fact, Tax-expressing cells show 
an increased mutation rate, consistent with an effect on cellular DNA repair (83,84). The 
cell has a variety o f mechanisms to repair damaged DNA including base excision repair 
(BER), mismatch repair (MMR), and non-homologous end-joining (NHEJ). While 
suppression of both BER and NER activity has been demonstrated in Tax-expressing 
cells (114,126,127), no studies have addressed the effect of Tax on the NHEJ pathway of 
repair.
Our laboratory has demonstrated a physical interaction between Tax and DNA- 
PKcs, a key enzyme involved in NHEJ repair. We also observed increased DNA-PK 
kinase activity in an in vitro assay in the presence of Tax. Furthermore, we found that 
Tax alters the regulation of this enzyme by increasing the forms of DNA-PKcs 
phosphorylated at serine 2056 (S2056) and threonine 2609 (T2609). Under normal 
conditions, following a DNA damage event, DNA-PKcs becomes phosphorylated at 
S2056 and T2609, and this phosphorylation is resolved after several hours during which 
time repair occurs (179,180). This event corresponds to the phosphorylation of histone 
variant H2AX at serine 139 (y-H2AX), which co-localizes with phosphor-DNA-PKcs at 
the sites o f DNA breaks (179,180). Interestingly, the process appears to be misregulated
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in Tax-expressing cells, in which the phosphorylation of both DNA-PKcs and H2AX 
remains many hours after the DNA damage event. Therefore, we postulate that Tax may 
affect the NHEJ pathway of repair by influencing the activity o f the key regulator, DNA- 
PK.
In the current study, we were unable to demonstrate a significant effect of Tax on 
cellular end-joining capacity, as measured by an in vivo plasmid-based end-joining assay. 
We cannot rule out the possibility that limitations in the assay design prevented us from 
detecting a difference between the repair capacities o f cells with and without Tax. For 
example, the assay measures completed repair at 48 h after introduction of a linearized 
reporter plasmid. We cannot measure a difference in rates of repair using this approach. 
Future experiments aimed at measuring rates and fidelity of end-joining in Tax- 
expressing cells will use a PCR-RFLP-based assay, modified from Wang et al. (216). 
E’coRI-digested pGL2 plasmid will be transfected into cells, and then analyzed at selected 
time points after transfection for recircularization. A PCR product will be amplified in 
the linear range by specific primers flanking the EcoKl site. If  the linearized pGL2 is 
rejoined precisely, the EcoBl site is regenerated and the PCR product can be digested by 
£■00111 to yield two small digestion fragments which can be resolved on an agarose gel 
containing ethidium bromide and quantified by densitometry. The £coRI-cut fragments 
represent the fraction of precise end-joining. The PCR product resistant to £coRI- 
digestion represents the imprecisely end-joined fraction. The effect of Tax on the rate of 
precise and imprecise end-joining can thus be determined. Furthermore, the exact nature 
of the misrepaired DNA can be determined by cloning the digestion-resistant fraction of 
the PCR product in bacteria and sequencing individual colonies. This assay can yield
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important information about the impact of Tax on the rate and fidelity o f end-joining 
repair, and may provide more insight than the luciferase-based assay conducted in the 
current study.
In the current study, we were also unable to demonstrate a role for DNA-PKcs in 
Tax-induced G2/M arrest. While DNA-PKcs may in fact not be required for this Tax 
effect, it remains a possibility that efficient siRNA delivery along with Tax was not 
sufficient to achieve complete knockdown of DNA-PKcs. The residual DNA-PK 
detected by immunoblot following simultaneous delivery of DNA-PKcs siRNA 
(PRKDC) and Tax (Fig 2B) may have been sufficient for activation o f the cell cycle 
checkpoint. Furthermore, efficient siRNA and STaxGFP DNA co-delivery to the same 
cells is required to observe an effect. While cell cycle analysis can be analyzed in the 
population of cells with Tax-GFP expression due to the fluorescent GFP tag, this 
population likely only contains a portion of cells which also received siRNA. Silencer 
Validated DNA-PKcs siRNA is now commercially available with a Cy3 fluorescent label 
(Ambion), which would allow detection of siRNA within cells via flow cytometry. By 
using this reagent in combination with STaxGFP, we can selectively analyze the cell 
cycle profile o f only the cell population which received both siRNA and STaxGFP DNA. 
Therefore, future studies aimed at optimizing siRNA delivery can readdress the role o f 
DNA-PKcs in Tax-induced G2 arrest.
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SECTION 7 
CONCLUSIONS
Summary
We have developed two model systems for isolating Tax complexes. Using a 
stable, inducible cell line Flp-In TREx-293-HisTaxGFP, we demonstrated successful 
affinity purification of His-tagged Tax and associated proteins using immobilized metal 
affinity resin. A second model employed affinity purification of S-tagged Tax in 
complex with cellular binding partners from transiently transfected human cells, using S- 
protein agarose beads. Using the S-tag model, we successfully isolated Tax complexes 
and identified the novel Tax-interacting protein DNA-PKcs by LC-MS/MS analysis. We 
further explored the Tax interactome via bioinformatics analysis. The Human Virus 
Interactome Resource (HVIR) was developed as an interactive database containing Tax 
interactions currently documented in the research literature. In addition, we developed a 
visual map of the direct Tax interactions along with ‘second neighbors’ of Tax, cellular 
proteins that interact with Tax-binding partners, as identified by automated searching of 
publicly available protein interaction databases. Analysis of the resulting Tax 
interactome suggested that the Tax-DNA-PK interaction could have been predicted with 
the use of HVIR.
Affinity purification of S-tagged Tax from human cells provided sufficient 
material to conduct a complete physical mapping of phosphorylation sites in Tax. This 
analysis, using LC-MS/MS and MALDI-TOF, resulted in identification of four novel 
sites of phosphorylation at T48, T184, T215 and S336, along with confirmation o f the
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previously identified phosphorylation at S300/301. Mutational analysis demonstrated 
phosphorylation at T215 is associated with loss of Tax rraws-activation o f CREB and NF- 
KB-responsive promoters, while T48 predominantly affects NF-KB-responsive promoters, 
and T184 and S336 have no effect on these Tax functions.
Following identification of DNA-PKcs in the affinity-purified Tax complex, we 
confirmed the interaction using co-immunoprecipitation experiments, and also identified 
the regulatory protein, Ku70, as a binding partner. Semi-quantitative RT-PCR suggests 
that Tax does not affect the gene expression o f DNA-PKcs. While the protein expression 
of DNA-PKcs is also not affected by Tax, phosphorylated DNA-PKcs is increased in 
Tax-expressing cells. Furthermore, Tax co-localizes with phosphor-DNA-PKcs in 
discrete nuclear foci. Select cytoplasmically-localized Tax deletion mutants cause a 
redistribution of phosphor-DNA-PKcs to the cytoplasm. DNA-PK kinase activity is 
increased in Tax-expressing cells. We also demonstrated the requirement for DNA-PK 
for the Tax-induced increase in Chk2 kinase activity. Tax alters the function o f DNA-PK 
in response to DNA damage, as demonstrated by a defect in resolving DNA damage- 
induced phosphor-DNA-PKcs and y-H2AX foci in Tax-expressing cells subjected to 
ionizing radiation.
A plasmid-based in vivo end-joining assay demonstrated no significant effect of 
Tax on cellular end-joining repair capacity. Suppression of DNA-PKcs by siRNA had to 
significant impact on Tax-induced G2/M arrest.
Significance of Findings
HTLV-1 has a global impact, with an estimated 20-30 million people infected
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
115
worldwide (22). HTLV-1 is endemic in distinct geographic areas, and presents a 
significant public health problem in regions such as the Caribbean, where 3-4% of the 
population is seropositive, and Japan, where an estimated 1.2 million individuals are 
infected (24-26). HTLV-1 infection is linked to two life-threatening and incurable 
diseases, ATL and HAM/TSP. More than 800 cases of ATL are diagnosed in Japan each 
year (25,26). Chemotherapy is ineffective at treating ATL, and patients with acute ATL 
have a median survival time of only 13 months, despite aggressive treatment (43).
Study of the molecular pathogenesis o f HTLV-1-mediated T-cell transformation 
is critical to improving ATL treatment regimens. The HTLV-1 viral oncoprotein Tax 
plays a central role in initiation of cellular transformation (115). While increasing 
evidence from our group and others has indicated that Tax expression results in loss o f 
genomic integrity, the mechanism by which this occurs in still not known. In the studies 
presented here, isolation of Tax protein for structural and functional mapping provides 
important insights into the regulation of Tax protein, and the impact of Tax on the DNA 
damage response pathway. This represents a significant contribution to understanding 
the mechanism of genomic instability induced by Tax.
In addition to analyzing Tax complexes in vivo, we used a bio informatics 
approach to explore the Tax interactome. The HVIR database we developed to map 
documented Tax interactions provides an important research tool. We demonstrated that 
this tool can be used to predict Tax-interacting proteins. The interactive design of this 
database allows the researcher to effectively evaluate what proteins might be logical 
binding partners of Tax, and this can guide experimentation in the laboratory.
The efficient isolation of Tax from human cells by affinity purification provided
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an excellent tool for examining the physical structure of Tax. We successfully generated 
a complete phosphopeptide map of Tax. Phosphorylation is an important mode of protein 
regulation. The identification of novel phosphorylation sites, which we further 
demonstrated are functionally significant for Tax transactivation, provides new 
information regarding Tax regulation. Since Tax affects so many cellular processes, 
understanding how it is regulated at the level of post-translational modifications is 
significant.
In addition to isolating Tax protein from human cells, we were able to pull down 
Tax-binding proteins in a complex by affinity purification. Further, we identified a novel 
Tax-interacting protein, DNA-PKcs. DNA-PK is a key enzyme in the cellular response 
to DNA damage. Since appropriate DNA repair is critical to maintaining the integrity of 
the genome, the interaction of Tax with DNA-PK is o f considerable interest. 
Significantly, we found that Tax-expressing cells have increased DNA-PK kinase 
activity. This has serious implications for genomic integrity, as it is evident that a 
number of tumors present increased DNA-PK activity correlated with chromosomal 
aberrations and other evidence of genomic instability (186-188). Interestingly, we found 
that Tax-expressing cells have a defect in resolving DNA damage-induced phosphor- 
DNA-PK and y-H2AX foci following ionizing radiation. This observation suggests that 
Tax alters DNA-PK function, interfering with the appropriate response to DNA damage. 
Collectively, these data suggest that the interaction of Tax with DNA-PK may contribute 
to the chromosomal aberrations observed in these cells, due to inappropriate regulation of 
the DNA repair pathway.
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We further addressed the significance of the Tax-DNA-PK interaction by 
examining end-joining repair and cell cycle control. While we hypothesized that Tax 
may affect cellular end-joining capacity, we were unable to show such an effect. 
However, modification of the assay may provide better insight into this function. 
Further, we were unable to show a requirement for DNA-PK in Tax-induced G2/M 
arrest. Optimization of the suppression o f DNA-PK may better resolve the role o f DNA- 
PK in this function.
The data presented in this work provides a significant contribution to our 
understanding of the mechanism of Tax-mediated genomic instability. We suggest that 
Tax interaction with DNA-PK perturbs the cellular response to DNA damage, resulting in 
inappropriate repair, and the accumulation of chromosomal abnormalities leading to loss 
of genomic integrity. The models for purification of Tax complexes, along with the 
HVIR Tax interactome database, provide invaluable tools for the continued analysis of 
Tax structure and function.
Future Directions
The S-tagged Tax purification system is an incredible tool for identifying Tax- 
interacting proteins. Continued optimization o f the affinity purification protocol can 
increase the number of proteins that we are able to identify in the Tax complex. One 
option is to enrich for subsets of proteins that we are interested in. For example, S-tagged 
Tax can be bound to the beads, and then subsequently incubated with concentrated 
cellular fractions, such as nuclear extracts, to increase the opportunity for identifying 
proteins o f low-abundance. In addition, the stringency of washes can be regulated to
R eproduced  with perm ission of the copyright owner. Further reproduction prohibited without perm ission.
118
allow for weaker binding partners to remain bound to the beads, and increase the number 
of identified proteins. Non-specific proteins can be reduced by utilizing the thrombin 
cleavage site, such that S-tagged Tax is bound to the beads and the Tax complex is 
removed by cleavage of the S-tag from the protein using thrombin. This protocol has 
already successfully been used as an alternative to elution (data not shown). In this way, 
proteins non-specifically bound to the beads will not be removed by thrombin cleavage as 
they would be by elution. More sensitive detection of the isolated protein complex can 
be achieved with 2-D gel electrophoresis. Preliminary experiments indicate that it is 
critical to decrease non-specific background since this method allows very sensitive 
protein detection (data not shown). Therefore, thrombin cleavage in combination with 2- 
D gel analysis may be advantageous.
It is o f considerable interest to examine Tax complexes in T-cells, which is the 
natural cell type for HTLV-1 infection. We are currently working on methods to express 
S-tagged Tax in T-cells for affinity purification. We have developed a lentiviral-based 
expression system (Invitrogen) to produce virus expressing STax and STaxGFP which 
can be used to infect T-cells for efficient expression of S-tagged Tax. Progress has been 
made in creating the expression vectors, and the production o f virus is underway (data 
not shown). Alternatively, the use o f newly-acquired Amaxa Nucleofector technology 
(Amaxa, Gaithersburg, MD) may provide us with another method for efficiently 
expressing S-tagged Tax in T-cells.
Besides isolating and identifying Tax-interacting proteins in T-cells, we are also 
interested in mapping Tax post-translational modifications in this cell type. Efficient 
expression and purification of S-tagged Tax in T-cells would allow us to perform LC-
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MS/MS analysis to determine if the same sites are phosphorylated as in 293T cells. In 
addition to phosphorylation, other post-translational modifications, such as ubiquitination 
and sumoylation, can be mapped in either 293T or T-cells by mass spectrometry analysis. 
We have developed phosphor-specific antibodies to T48, T215 and S300/301 which we 
can use to further investigate the functional significance of this phosphorylation. 
Preliminary experiments with these antibodies suggest that they are indeed phosphor- 
specific (data not shown). The antibodies can be used to assess Tax phosphorylation 
status in different cell types, the localization of phosphor-forms and other important 
characteristics. In addition, further studies using the phosphor-specific mutants can be 
designed to examine the requirement o f phosphorylation for other Tax functions, such as 
interaction with DNA damage response pathway components.
Considering the range of DNA-PK function, there are many questions we can 
address about the significance of the Tax-DNA-PK interaction. Optimization of the end- 
joining repair assay, as described in the discussion in Section VI, may show an impact of 
Tax on this form of repair. In addition, improved suppression of DNA-PKcs would allow 
better assessment of its role in Tax-induced G2/M arrest. Future studies examining the 
role o f Tax and DNA-PK in myc regulation, p53 function, and telomerase capping would 
all be valuable.
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